10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2022

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number: 000-06936

Commission Company Name: WD 40 CO

WD-40 COMPANY

(Exact name of registrant as specified in its charter)

Delaware	95-1797918
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
9715 Businesspark Avenue, San Diego, California	92131
(Address of principal executive offices)	(Zip code)

Registrant’s telephone number, including area code: (619) 275-1400

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of exchange on which registered
Common stock, par value $0.001 per share	WDFC	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  þ     No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  þ        Accelerated filer  ¨  Non-accelerated filer  ¨       Smaller reporting company  ¨

Emerging growth company  ¨       

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  ¨    No  þ

The number of outstanding shares of the registrant’s common stock, par value $0.001 per share, as of April 4, 2022 was 13,660,980.

1

WD-40 COMPANY

QUARTERLY REPORT ON FORM 10-Q

For the Quarter Ended February 28, 2022

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
		Page
Item 1.	Financial Statements (Unaudited)
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Operations	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statement of Shareholders’ Equity	6
	Condensed Consolidated Statements of Cash Flows	8
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	38
Item 4.	Controls and Procedures	38
PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	39
Item 1A.	Risk Factors	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
Item 6.	Exhibits	40

2

PART 1 - FINANCIAL INFORMATION
Item 1. Financial Statements
WD-40 COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited and in thousands, except share and per share amounts)
	February 28,		August 31,
	2022		2021
Assets
Current assets:
Cash and cash equivalents	$	43,322	$	85,961
Trade and other accounts receivable, less allowance for doubtful
accounts of $366 and $463 at February 28, 2022
and August 31, 2021, respectively		103,582		89,558
Inventories		75,537		55,752
Other current assets		12,158		9,948
Total current assets		234,599		241,219
Property and equipment, net		69,334		70,145
Goodwill		95,754		95,869
Other intangible assets, net		6,478		7,244
Operating lease right-of-use assets		8,115		8,824
Deferred tax assets, net		853		858
Other assets		8,013		6,044
Total assets	$	423,146	$	430,203
Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable	$	39,655	$	33,499
Accrued liabilities		28,130		25,658
Accrued payroll and related expenses		13,133		25,662
Short-term borrowings		2,038		800
Income taxes payable		433		317
Total current liabilities		83,389		85,936
Long-term borrowings		112,809		114,940
Deferred tax liabilities, net		10,717		10,401
Long-term operating lease liabilities		6,356		7,062
Other long-term liabilities		11,025		11,482
Total liabilities		224,296		229,821
Commitments and Contingencies (Note 11)
Shareholders' equity:
Common stock ― authorized 36,000,000 shares, $0.001 par value;
19,887,516 and 19,856,865 shares issued at February 28, 2022 and
August 31, 2021, respectively; and 13,660,980 and 13,708,966 shares
outstanding at February 28, 2022 and August 31, 2021, respectively		20		20
Additional paid-in capital		164,192		163,737
Retained earnings		448,179		430,735
Accumulated other comprehensive loss		(27,296)		(26,030)
Common stock held in treasury, at cost ― 6,226,536 and 6,147,899
shares at February 28, 2022 and August 31, 2021, respectively		(386,245)		(368,080)
Total shareholders' equity		198,850		200,382
Total liabilities and shareholders' equity	$	423,146	$	430,203
See accompanying notes to condensed consolidated financial statements.

3

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited and in thousands, except per share amounts)
	Three Months Ended February 28,				Six Months Ended February 28,
		2022		2021		2022		2021
Net sales	$	129,986	$	111,905	$	264,732	$	236,464
Cost of products sold		64,468		49,898		130,744		104,211
Gross profit		65,518		62,007		133,988		132,253
Operating expenses:
Selling, general and administrative		34,819		35,478		73,242		71,455
Advertising and sales promotion		5,596		5,512		11,220		11,031
Amortization of definite-lived intangible assets		360		362		723		720
Total operating expenses		40,775		41,352		85,185		83,206
Income from operations		24,743		20,655		48,803		49,047
Other income (expense):
Interest income		21		19		46		38
Interest expense		(613)		(610)		(1,233)		(1,180)
Other income (expense), net		252		151		(77)		330
Income before income taxes		24,403		20,215		47,539		48,235
Provision for income taxes		4,895		3,024		9,476		7,421
Net income	$	19,508	$	17,191	$	38,063	$	40,814
Earnings per common share:
Basic	$	1.41	$	1.25	$	2.76	$	2.97
Diluted	$	1.41	$	1.24	$	2.75	$	2.96
Shares used in per share calculations:
Basic		13,679		13,700		13,773		13,687
Diluted		13,704		13,729		13,804		13,718
See accompanying notes to condensed consolidated financial statements.

‎

4

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited and in thousands)
	Three Months Ended February 28,				Six Months Ended February 28,
		2022		2021		2022		2021
Net income	$	19,508	$	17,191	$	38,063	$	40,814
Other comprehensive income (loss):
Foreign currency translation adjustment		627		3,234		(1,266)		3,822
Total comprehensive income	$	20,135	$	20,425	$	36,797	$	44,636
See accompanying notes to condensed consolidated financial statements.

5

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(Unaudited and in thousands, except share and per share amounts)
								Accumulated
				Additional				Other					Total
	Common Stock			Paid-in		Retained		Comprehensive		Treasury Stock			Shareholders'
	Shares	Amount		Capital		Earnings		Income (Loss)		Shares	Amount		Equity
Balance at August 31, 2021	19,856,865	$	20	$	163,737	$	430,735	$	(26,030)	6,147,899	$	(368,080)	$	200,382
Issuance of common stock under share-based
compensation plan, net of shares withheld for taxes	30,072		-		(4,246)									(4,246)
Stock-based compensation					2,891									2,891
Cash dividends ($0.72 per share)							(9,905)							(9,905)
Acquisition of treasury stock										32,000		(7,386)		(7,386)
Foreign currency translation adjustment									(1,893)					(1,893)
Net income							18,555							18,555
Balance at November 30, 2021	19,886,937	$	20	$	162,382	$	439,385	$	(27,923)	6,179,899	$	(375,466)	$	198,398
Issuance of common stock under share-based
compensation plan, net of shares withheld for taxes	579		-		(75)									(75)
Stock-based compensation					1,885									1,885
Cash dividends ($0.78 per share)							(10,714)							(10,714)
Acquisition of treasury stock										46,637		(10,779)		(10,779)
Foreign currency translation adjustment									627					627
Net income							19,508							19,508
Balance at February 28, 2022	19,887,516	$	20	$	164,192	$	448,179	$	(27,296)	6,226,536	$	(386,245)	$	198,850

See accompanying notes to condensed consolidated financial statements.

6

								Accumulated
				Additional				Other					Total
	Common Stock			Paid-in		Retained		Comprehensive		Treasury Stock			Shareholders'
	Shares	Amount		Capital		Earnings		Income (Loss)		Shares	Amount		Equity
Balance at August 31, 2020	19,812,685	$	20	$	157,850	$	398,731	$	(28,208)	6,147,899	$	(368,080)	$	160,313
Issuance of common stock under share-based
compensation plan, net of shares withheld for taxes	23,417		-		(3,490)									(3,490)
Stock-based compensation					2,665									2,665
Cash dividends ($0.67 per share)							(9,199)							(9,199)
Foreign currency translation adjustment									588					588
Net income							23,623							23,623
Balance at November 30, 2020	19,836,102	$	20	$	157,025	$	413,155	$	(27,620)	6,147,899	$	(368,080)	$	174,500
Issuance of common stock under share-based
compensation plan, net of shares withheld for taxes	19,564		-		(5)									(5)
Stock-based compensation					1,877									1,877
Cash dividends ($0.67 per share)							(9,217)							(9,217)
Acquisition of treasury stock														-
Foreign currency translation adjustment									3,234					3,234
Net income							17,191							17,191
Balance at February 28, 2021	19,855,666	$	20	$	158,897	$	421,129	$	(24,386)	6,147,899	$	(368,080)	$	187,580
See accompanying notes to condensed consolidated financial statements.

7

WD-40 COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited and in thousands)
	Six Months Ended February 28,
	2022		2021
Operating activities:
Net income	$	38,063	$	40,814
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization		4,082		3,458
Net gains on sales and disposals of property and equipment		(123)		(104)
Deferred income taxes		367		152
Stock-based compensation		4,776		4,542
Unrealized foreign currency exchange (gains) losses		(110)		139
Provision for bad debts		(55)		175
Changes in assets and liabilities:
Trade and other accounts receivable		(15,178)		(10,111)
Inventories		(20,369)		(2,104)
Other assets		(4,328)		(4,386)
Operating lease assets and liabilities, net		1		9
Accounts payable and accrued liabilities		9,624		7,398
Accrued payroll and related expenses		(12,356)		1,584
Other long-term liabilities and income taxes payable		(311)		944
Net cash provided by operating activities		4,083		42,510
Investing activities:
Purchases of property and equipment		(3,860)		(7,605)
Proceeds from sales of property and equipment		289		239
Net cash used in investing activities		(3,571)		(7,366)
Financing activities:
Treasury stock purchases		(18,165)		-
Dividends paid		(20,619)		(18,416)
Proceeds from issuance of long-term senior notes		-		52,000
Repayments of long-term senior notes		(400)		(400)
Net proceeds (repayments) of revolving credit facility		1,238		(50,000)
Shares withheld to cover taxes upon conversions of equity awards		(4,321)		(3,495)
Net cash used in financing activities		(42,267)		(20,311)
Effect of exchange rate changes on cash and cash equivalents		(884)		1,086
Net (decrease) increase in cash and cash equivalents		(42,639)		15,919
Cash and cash equivalents at beginning of period		85,961		56,462
Cash and cash equivalents at end of period	$	43,322	$	72,381
Supplemental disclosure of noncash investing activities:
Accrued capital expenditures	$	798	$	1,638
See accompanying notes to condensed consolidated financial statements.

‎

8

WD-40 COMPANY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1. The Company

WD-40 Company (the “Company”), based in San Diego, California, is a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories and homes around the world. The Company owns a wide range of well-known brands that include maintenance products and homecare and cleaning products: WD-40® Multi-Use Product, WD-40 Specialist®, 3-IN-ONE®, GT85®, 2000 Flushes®, no vac®, 1001®, Spot Shot®, Lava®, Solvol®, X-14®,and Carpet Fresh®.

The Company’s products are sold in various locations around the world. Maintenance products are sold worldwide in markets throughout North, Central and South America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold primarily in North America, the United Kingdom (“U.K.”) and Australia. The Company’s products are sold primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial distributors and suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike dealers.

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Consolidation

The condensed consolidated financial statements included herein have been prepared by the Company, without audit, according to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The August 31, 2021 year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

In the opinion of management, the unaudited financial information for the interim periods shown reflects all adjustments necessary for a fair statement thereof and such adjustments are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.

COVID-19 Considerations

The COVID-19 pandemic has adversely impacted global economic conditions and has contributed to significant volatility in financial markets beginning in early calendar year 2020, as described in the “Impact of COVID-19 on Our Business” portion of the section titled “Significant Developments” included in Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Although the Company’s estimates consider current conditions, the inputs into certain of the Company’s significant and critical accounting estimates include judgments and assumptions about the economic implications of the COVID-19 pandemic and how management expects them to change in the future, as appropriate.

9

It is reasonably possible that actual results experienced may differ materially from the Company’s estimates in future periods, which could materially affect our results of operations and financial condition.

Foreign Currency Forward Contracts

In the normal course of business, the Company employs established policies and procedures to manage its exposure to fluctuations in foreign currency exchange rates. The Company utilizes foreign currency forward contracts to limit its exposure to net asset balances held in non-functional currencies, primarily at its U.K. subsidiary. The Company regularly monitors its foreign currency exchange rate exposures to ensure the overall effectiveness of its foreign currency hedge positions. While the Company engages in foreign currency hedging activity to reduce its risk, for accounting purposes, none of its foreign currency forward contracts are designated as hedges.

Foreign currency forward contracts are carried at fair value, with net realized and unrealized gains and losses recognized in other income (expense), net in the Company’s consolidated statements of operations. Cash flows from settlements of foreign currency forward contracts are included in operating activities in the consolidated statements of cash flows. Foreign currency forward contracts in an asset position at the end of the reporting period are included in other current assets, while foreign currency forward contracts in a liability position at the end of the reporting period are included in accrued liabilities in the Company’s consolidated balance sheets. At February 28, 2022, the Company had a notional amount of $4.5 million outstanding in foreign currency forward contracts, which matured on March 30, 2022. Unrealized net gains and losses related to foreign currency forward contracts were not significant at February 28, 2022 and August 31, 2021. Realized net gains and losses related to foreign currency forward contracts were not significant for both the three and six months ended February 28, 2022 and 2021. Both unrealized and realized net gains and losses are recorded in other income (expense), net on the Company’s condensed consolidated statements of operations.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial assets and liabilities measured at fair value into a hierarchy that categorizes fair value measurements into the following three levels based on the types of inputs used in measuring their fair value: 

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities;

Level 2: Observable market-based inputs or observable inputs that are corroborated by market data; and

Level 3: Unobservable inputs reflecting the Company’s own assumptions.

Under fair value accounting, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. As of February 28, 2022, the Company had no assets or liabilities that are measured at fair value in the financial statements on a recurring basis, with the exception of the foreign currency forward contracts, which are classified as Level 2 within the fair value hierarchy. The carrying values of cash equivalents and short-term borrowings are recorded at cost, which approximates their fair values, primarily due to their short-term nature. In addition, the carrying value of borrowings held under the Company’s revolving credit facility approximates fair value, based on Level 2 inputs, due to the variable nature of underlying interest rates, which generally reflect market conditions. The Company’s fixed rate long-term borrowings consist of senior notes and are recorded at carrying value. The Company estimates that the fair value of its senior notes, based on Level 2 inputs, was approximately $64.8 million as of February 28, 2022, which was determined based on a discounted cash flow analysis using current market interest rates for instruments with similar terms, compared to their carrying value of $68.8 million. During the six months ended February 28, 2022, the Company did not record any significant nonrecurring fair value measurements for assets or liabilities in periods subsequent to their initial recognition.

‎

10

Internal-Use Software and Cloud Computing Arrangements

The Company capitalizes costs related to computer software obtained or developed for internal use. Software obtained for internal use has generally been enterprise-level business and finance software that the Company customizes to meet its specific operational needs. Costs incurred in the application development phase are capitalized as property and equipment in the Company’s consolidated balance sheets and are depreciated using the straight-line method over their estimated useful lives.

The Company also enters into certain cloud-based software hosting arrangements. In evaluating whether cloud computing arrangements include an embedded internal-use software license, management considers whether the Company has the contractual right to take possession of the software during the hosting period without significant penalty and whether it is feasible to either i) run the software on the Company’s hardware, or ii) contract with another party unrelated to the vendor to host the software. If management determines a cloud computing arrangement includes an embedded software license, the Company accounts for the software license element of the arrangement consistent with the acquisition of other internal-use software licenses. If a cloud computing arrangement does not include a software license, the Company accounts for the arrangement as a service contract. For such cloud computing service contracts, the Company capitalizes certain implementation costs such as the configuration, coding and customization of the software. Capitalizable cloud computing arrangement costs are generally consistent with those incurred during the application development stage for internal-use software, however, these costs are capitalized as “other assets” in the Company’s consolidated balance sheets. The Company amortizes these capitalized cloud computing implementation costs into selling, general and administrative expenses using the straight-line method over the fixed, non-cancellable term of the associated hosting arrangement, plus any reasonably certain renewal periods.

The useful lives of the Company’s internal-use software and capitalized cloud computing implementation costs are generally three to five years. However, the useful lives of major information system installations such as implementations of enterprise resource planning (“ERP”) systems are determined on an individual basis and may exceed five years depending on the estimated period of use. The Company applies the same impairment model to both internal-use software and capitalized cloud computing implementation costs.

Recently Adopted Accounting Standards

In December 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes” under ASC 740, which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amended existing guidance to improve consistent application. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The Company adopted this new guidance on September 1, 2021, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.

Note 3. Inventories

Inventories are stated at the lower of cost or net realizable value and cost is determined based on a first-in, first-out method or, for a portion of raw materials inventory, the average cost method. Inventories consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Product held at third-party contract manufacturers	$	7,218	$	9,036
Raw materials and components		12,526		8,981
Work-in-process		1,379		802
Finished goods		54,414		36,933
Total	$	75,537	$	55,752

11

Note 4. Property and Equipment and Capitalized Cloud-Based Software Implementation Costs

Property and equipment, net, consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Machinery, equipment and vehicles	$	36,004	$	22,504
Buildings and improvements		29,655		29,697
Computer and office equipment		6,094		5,742
Internal-use software		10,785		10,559
Furniture and fixtures		2,809		2,794
Capital in progress		18,236		31,016
Land		4,379		4,406
Subtotal		107,962		106,718
Less: accumulated depreciation and amortization		(38,628)		(36,573)
Total	$	69,334	$	70,145

At August 31, 2021, capital in progress on the balance sheet included $30.3 million associated with capital costs related to proprietary machinery and equipment for the Company’s next generation of delivery systems for its WD-40 Smart Straw^® products. During the six months ended February 28, 2022, $13.5 million of this machinery and equipment was placed in service and thus the Company reclassified these amounts from capital in progress to machinery, equipment and vehicles.

As of February 28, 2022 and August 31, 2021, the Company’s balance sheet included $4.7 million and $2.6 million, respectively, of capitalized cloud-based implementation costs recorded as other assets within the Company’s condensed consolidated balance sheets. Accumulated amortization associated with these assets were not significant as of February 28, 2022 and August 31, 2021. Amortization expense associated with these assets were not significant for the three or six months ended February 28, 2022 or February 28, 2021.

Note 5. Goodwill and Other Intangible Assets

Goodwill

The following table summarizes the changes in the carrying amounts of goodwill by segment (in thousands):

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	85,476	$	9,184	$	1,209	$	95,869
Translation adjustments		(12)		(103)		-		(115)
Balance as of February 28, 2022	$	85,464	$	9,081	$	1,209	$	95,754

During the second quarter of fiscal year 2022, the Company performed its annual goodwill impairment test. The annual goodwill impairment test was performed at the reporting unit level as required by the authoritative guidance as of the Company’s most recent goodwill impairment testing date, December 1, 2021. During the fiscal year 2022 annual goodwill impairment test, the Company performed a qualitative assessment of each reporting unit to determine whether it was more likely than not that the fair value of a reporting unit was less than its carrying amount. In performing this qualitative assessment, the Company assessed relevant events and circumstances that may impact the fair value and the carrying amount of each of its reporting units. Factors that were considered included, but were not limited to, the following: (1) macroeconomic conditions, including the impacts of the COVID-19 pandemic; (2) industry and market conditions; (3) historical financial performance and expected financial performance; (4) other entity specific events, such as changes in management or key personnel; and (5) events affecting the Company’s reporting units, such as a change in the composition of net assets or any expected dispositions.

‎

12

Based on the results of this qualitative assessment, the Company determined that the estimated fair value of each of the Company’s reporting units exceeded their respective carrying values so significantly that an impairment charge to the Company’s goodwill balances is remote and, thus, a quantitative analysis was not required. As a result, the Company concluded that no impairment of its goodwill existed as of December 1, 2021. In addition, the Company concluded that there were no indicators of impairment identified as a result of the Company’s review of events and circumstances related to its goodwill subsequent to December 1, 2021 through February 28, 2022. To date, there have been no impairment losses identified and recorded related to the Company’s goodwill.

Definite-lived Intangible Assets

The Company’s definite-lived intangible assets, which include the Spot Shot, Carpet Fresh, 1001, EZ REACH and GT85 trade names, are included in other intangible assets, net in the Company’s condensed consolidated balance sheets. The following table summarizes the definite-lived intangible assets and the related accumulated amortization (in thousands):

	February 28,		August 31,
	2022		2021
Gross carrying amount	$	36,407	$	36,657
Accumulated amortization		(29,929)		(29,413)
Net carrying amount	$	6,478	$	7,244

There has been no impairment charge for the six months ended February 28, 2022 and there were no indicators of impairment identified as a result of the Company’s review of events and circumstances related to its existing definite-lived intangible assets. The Company’s review of events and circumstances included consideration of the ongoing COVID-19 pandemic.

Changes in the carrying amounts of definite-lived intangible assets by segment for the six months ended February 28, 2022 are summarized below (in thousands):

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	5,495	$	1,749	$	-	$	7,244
Amortization expense		(528)		(195)		-		(723)
Translation adjustments		-		(43)		-		(43)
Balance as of February 28, 2022	$	4,967	$	1,511	$	-	$	6,478

The estimated amortization expense for the Company’s definite-lived intangible assets is not significant in any future individual fiscal year.

‎

13

Note 6. Accrued and Other Liabilities

Accrued liabilities consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Accrued advertising and sales promotion expenses	$	12,308	$	11,796
Accrued professional services fees		2,134		2,122
Accrued sales taxes and other taxes		3,462		1,708
Deferred revenue		3,976		3,696
Short-term operating lease liability		1,866		1,903
Other		4,384		4,433
Total	$	28,130	$	25,658

Accrued payroll and related expenses consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Accrued incentive compensation	$	4,800	$	14,068
Accrued payroll		4,728		4,746
Accrued profit sharing		1,068		3,273
Accrued payroll taxes		1,975		2,952
Other		562		623
Total	$	13,133	$	25,662

Note 7. Debt

As of February 28, 2022, the Company held borrowings under two separate agreements as detailed below.

Note Purchase and Private Shelf Agreement

The Company holds borrowings under its Note Purchase and Private Shelf Agreement (the “Note Agreement”) by and among the Company, PGIM, Inc. (“Prudential”), and certain affiliates and managed accounts of Prudential (the “Note Purchasers”). As of February 28, 2022, the Company had outstanding balances on its series A, B and C notes issued under this Note Agreement.

Credit Agreement

The Company’s Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America consists of a revolving commitment for borrowing by the Company up to $150.0 million with a sublimit of $100.0 million for WD-40 Company Limited, a wholly owned operating subsidiary of the Company for Europe, the Middle East, Africa and India. The Credit Agreement currently has a maturity date of September 30, 2025.

On November 29, 2021, the Company entered into its most recent amendment to the Credit Agreement (the “LIBOR Amendment”) with Bank of America. The LIBOR Amendment changed the Company’s index rates under the Credit Agreement for British Pound Sterling and U.S. Dollar borrowings from the London Interbank Offered Rate as administered by ICE Benchmark Administration to the Sterling Overnight Index Average Reference Rate and the Bloomberg Short-term Bank Yield Index rate, respectively, as well as certain definitions and clarifications within the Credit Agreement to accommodate the change in index rates. The impact of the LIBOR Amendment was insignificant to the Company’s consolidated financial statements.

14

Short-term and long-term borrowings under the Company’s Credit Agreement and Note Agreement consisted of the following (in thousands):

			February 28,		August 31,
	Issuance	Maturities	2022		2021
Credit Agreement - revolving credit facility (1)	Various	9/30/2025	$	46,047	$	46,540
Note Agreement
Series A Notes - 3.39% fixed rate(2)	11/15/2017	2021-2032		16,800		17,200
Series B Notes - 2.50% fixed rate(3)	9/30/2020	11/15/2027		26,000		26,000
Series C Notes - 2.69% fixed rate(3)	9/30/2020	11/15/2030		26,000		26,000
Total borrowings				114,847		115,740
Short-term portion of borrowings				(2,038)		(800)
Total long-term borrowings			$	112,809	$	114,940

(1)The Company has the ability to refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million on this facility is classified as long-term and is denominated in Euros and Pound Sterling, whereas $1.2 million is classified as short-term and is denominated in U.S. Dollar. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.

(2)Principal payments are required semi-annually in May and November of each year in equal installments of $0.4 million through May 15, 2032, resulting in $0.8 million classified as short-term. The remaining outstanding principal in the amount of $8.4 million will become due on November 15, 2032.

(3)Interest on notes is payable semi-annually in May and November of each year with no principal due until the maturity date.

Both the Note Agreement and the Credit Agreement contain representations, warranties, events of default and remedies, as well as affirmative, negative and other financial covenants customary for these types of agreements. These covenants include, among other things, certain limitations on the ability of the Company and its subsidiaries to incur indebtedness, create liens, dispose of assets, make investments, declare, make or incur obligations to make certain restricted payments, including the payment of dividends and payments for the repurchase of the Company’s capital stock and enter into certain merger or consolidation transactions. The Credit Agreement includes, among other limitations on indebtedness, a $125.0 million limit on other unsecured indebtedness.

Each agreement also includes a most favored lender provision which requires that any time any other lender has the benefit of one or more financial or operational covenants that is different than, or similar to, but more restrictive than those contained in its own agreement, those covenants shall be immediately and automatically incorporated by reference to the other lender’s agreement. Both the Note Agreement and the Credit Agreement require the Company to adhere to the same financial covenants. For the financial covenants, the definition of consolidated EBITDA includes the add back of non-cash stock-based compensation to consolidated net income when arriving at consolidated EBITDA. The terms of the financial covenants are as follows:

The consolidated leverage ratio cannot be greater than three and a half to one. The consolidated leverage ratio means, as of any date of determination, the ratio of (a) consolidated funded indebtedness as of such date to (b) consolidated EBITDA for the most recently completed four fiscal quarters.

The consolidated interest coverage ratio cannot be less than three to one. The consolidated interest coverage ratio means, as of any date of determination, the ratio of (a) consolidated EBITDA for the most recently completed four fiscal quarters to (b) consolidated interest charges for the most recently completed four fiscal quarters

As of February 28, 2022, the Company was in compliance with all debt covenants under both the Note Agreement and the Credit Agreement.

‎

15

Note 8. Share Repurchase Plan

On October 12, 2021, the Company’s Board of Directors (“Board”) approved a new share repurchase plan. Under the plan, which became effective on November 1, 2021, the Company is authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023. The timing and amount of repurchases are based on terms and conditions as may be acceptable to the Company’s Chief Executive Officer and Chief Financial Officer, subject to present loan covenants and in compliance with all laws and regulations applicable thereto. During the period from November 1, 2021 through February 28, 2022, the Company repurchased 78,637 shares at an average price of $230.98 per share, for a total cost of $18.2 million under this $75.0 million plan.

Note 9. Earnings per Common Share

The table below reconciles net income to net income available to common shareholders (in thousands):

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Net income	$	19,508	$	17,191	$	38,063	$	40,814
Less: Net income allocated to
participating securities		(73)		(64)		(137)		(174)
Net income available to common shareholders	$	19,435	$	17,127	$	37,926	$	40,640

The table below summarizes the weighted-average number of common shares outstanding included in the calculation of basic and diluted EPS (in thousands):

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Weighted-average common
shares outstanding, basic		13,679		13,700		13,773		13,687
Weighted-average dilutive securities		25		29		31		31
Weighted-average common
shares outstanding, diluted		13,704		13,729		13,804		13,718

For the three and six months ended February 28, 2022, weighted-average stock-based equity awards outstanding that are non-participating securities in the amount of 9,280 and 7,212, respectively, were excluded from the calculation of diluted EPS under the treasury stock method as they were anti-dilutive. For the three and six months ended February 28, 2021, there were no anti-dilutive stock-based equity awards outstanding.

‎

16

Note 10. Revenue Recognition

Disaggregation of Revenue

The following table presents our revenues by segment and major source (in thousands):

:

	Three Months Ended February 28, 2022:								Six Months Ended February 28, 2022:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	50,409	$	52,093	$	19,399	$	121,901	$	102,393	$	107,536	$	38,002	$	247,931
HCCP (1)		4,088		1,970		2,027		8,085		8,392		4,082		4,327		16,801
Total net sales	$	54,497	$	54,063	$	21,426	$	129,986	$	110,785	$	111,618	$	42,329	$	264,732
	Three Months Ended February 28, 2021:								Six Months Ended February 28, 2021:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	41,310	$	47,736	$	13,682	$	102,728	$	89,812	$	100,114	$	27,146	$	217,072
HCCP (1)		4,847		2,077		2,253		9,177		10,532		4,449		4,411		19,392
Total net sales	$	46,157	$	49,813	$	15,935	$	111,905	$	100,344	$	104,563	$	31,557	$	236,464

(1)Homecare and cleaning products (“HCCP”)

Contract Balances

Contract liabilities consist of deferred revenue related to undelivered products. Deferred revenue is recorded when payments have been received from customers for undelivered products. Revenue is subsequently recognized when revenue recognition criteria are met, generally when control of the product transfers to the customer. The Company had contract liabilities of $4.0 million and $3.7 million as of February 28, 2022 and August 31, 2021, respectively. All of the $3.7 million that was included in contract liabilities as of August 31, 2021 was recognized to revenue during the six months ended February 28, 2022. These contract liabilities are recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. The Company did not have any contract assets as of February 28, 2022 and August 31, 2021.

Note 11. Commitments and Contingencies

Purchase Commitments

The Company has ongoing relationships with various suppliers (contract manufacturers) that manufacture the Company’s products and third-party distribution centers that warehouse and ship the Company’s products to customers. The contract manufacturers maintain title and control of certain raw materials and components, materials utilized in finished products, and of the finished products themselves until shipment to the Company’s customers or third-party distribution centers in accordance with agreed upon shipment terms. Although the Company has definitive minimum purchase obligations included in the contract terms with certain of its contract manufacturers, when such obligations have been included, they have either been immaterial or the minimum amounts have been such that they are well below the volume of goods that the Company has historically purchased. In the ordinary course of business, supply needs are communicated by the Company to its contract manufacturers based on orders and short-term projections, ranging from two months to six months. The Company is committed to purchase the products produced by the contract manufacturers based on the projections provided.

Upon the termination of contracts with contract manufacturers, the Company obtains certain inventory control rights and is obligated to work with the contract manufacturer to sell through all product held by or manufactured by the contract manufacturer on behalf of the Company during the termination notification period. If any inventory remains at the contract manufacturer at the termination date, the Company is obligated to purchase such inventory which may include raw materials, components and finished goods. The amounts for inventory purchased under termination commitments have been immaterial. 

In addition to the commitments to purchase products from contract manufacturers described above, the Company may also enter into commitments with other manufacturers to purchase finished goods and components to support innovation and renovation initiatives and/or supply chain initiatives. As of February 28, 2022, no such commitments were outstanding.

17

Litigation

From time to time, the Company is subject to various claims, lawsuits, investigations and proceedings arising in the ordinary course of business, including but not limited to, product liability litigation and other claims and proceedings with respect to intellectual property, breach of contract, labor and employment, tax and other matters. As of February 28, 2022, there were no unasserted claims or pending proceedings for claims against the Company that the Company believes will result in a probable loss. As to claims that the Company believes may result in a reasonably possible loss, the Company believes that no reasonably possible outcome of any such claim will have a materially adverse impact on the Company’s financial condition, results of operations or cash flows.

For further information on the risks the Company faces from existing and future claims, lawsuits, investigations and proceedings, see the Company’s risk factors disclosed in Part I―Item 1A, “Risk Factors,” in its Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

Indemnifications

As permitted under Delaware law, the Company has agreements whereby it indemnifies senior officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company maintains Director and Officer insurance coverage that mitigates the Company’s exposure with respect to such obligations. As a result of the Company’s insurance coverage, management believes that the estimated fair value of these indemnification agreements is minimal. Thus, no liabilities have been recorded for these agreements as of February 28, 2022.

From time to time, the Company enters into indemnification agreements with certain contractual parties in the ordinary course of business, including agreements with lenders, lessors, contract manufacturers, marketing distributors, customers and certain vendors. All such indemnification agreements are entered into in the context of the particular agreements and are provided in an attempt to properly allocate risk of loss in connection with the consummation of the underlying contractual arrangements. Although the maximum future payments that the Company could be required to make under these indemnification agreements is unlimited, management believes that the Company maintains adequate levels of insurance coverage to protect the Company with respect to most potential claims arising from such agreements and that such agreements do not otherwise have value separate and apart from the liabilities incurred in the ordinary course of the Company’s business. Thus, no liabilities have been recorded with respect to such indemnification agreements as of February 28, 2022.

Note 12. Income Taxes

The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

The provision for income taxes was 20.1% and 15.0% of income before income taxes for the three months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to a non-recurring benefit received in the prior year from the settlement of stock-based equity awards.

The provision for income taxes was 19.9% and 15.4% of income before income taxes for the six months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to non-recurring benefits received in the prior year from stock-based compensation, coupled with an increase in performance-based compensation that is not deductible for tax purposes in the current year.

The Company is subject to taxation in the U.S. and in various state and foreign jurisdictions. Due to expired statutes, the Company’s federal income tax returns for years prior to fiscal year 2018 are not subject to examination by the U.S. Internal Revenue Service. Generally, for the majority of state and foreign jurisdictions where the Company does business, periods prior to fiscal year 2018 are no longer subject to examination. The Company is currently under audit in various state jurisdictions for fiscal years 2018 through 2020. Estimated unrecognized tax benefits related to income tax positions affected

18

by the resolution of tax examinations or expiring statutes of limitation within the next twelve months were not significant. Audit outcomes and the timing of settlements are subject to significant uncertainty.

Note 13. Business Segments and Foreign Operations

The Company evaluates the performance of its segments and allocates resources to them based on sales and operating income. The Company is organized on the basis of geographical area into the following three segments: the Americas; EMEA; and Asia-Pacific. Segment data does not include inter-segment revenues. Unallocated corporate expenses are general corporate overhead expenses not directly attributable to the business segments and are reported separate from the Company’s identified segments. The corporate overhead costs include expenses for the Company’s accounting and finance, information technology, human resources, research and development, quality control and executive management functions, as well as all direct costs associated with public company compliance matters including legal, audit and other professional services costs.

Summary information about reportable segments is as follows (in thousands):

							Unallocated
For the Three Months Ended	Americas		EMEA		Asia-Pacific		Corporate (1)		Total
February 28, 2022:
Net sales	$	54,497	$	54,063	$	21,426	$	-	$	129,986
Income from operations	$	11,217	$	13,715	$	7,925	$	(8,114)	$	24,743
Depreciation and
amortization expense	$	1,169	$	813	$	70	$	43	$	2,095
Interest income	$	-	$	-	$	21	$	-	$	21
Interest expense	$	486	$	125	$	2	$	-	$	613
February 28, 2021:
Net sales	$	46,157	$	49,813	$	15,935	$	-	$	111,905
Income from operations	$	10,356	$	14,176	$	5,188	$	(9,065)	$	20,655
Depreciation and
amortization expense	$	795	$	807	$	75	$	80	$	1,757
Interest income	$	-	$	3	$	16	$	-	$	19
Interest expense	$	491	$	118	$	1	$	-	$	610
Six Months Ended:
February 28, 2022:
Net sales	$	110,785	$	111,618	$	42,329	$	-	$	264,732
Income from operations	$	23,234	$	27,928	$	15,227	$	(17,586)	$	48,803
Depreciation and
amortization expense	$	2,212	$	1,597	$	144	$	129	$	4,082
Interest income	$	-	$	-	$	46	$	-	$	46
Interest expense	$	984	$	246	$	3	$	-	$	1,233
February 28, 2021:
Net sales	$	100,344	$	104,563	$	31,557	$	-	$	236,464
Income from operations	$	24,982	$	31,919	$	10,247	$	(18,101)	$	49,047
Depreciation and
amortization expense	$	1,586	$	1,563	$	151	$	158	$	3,458
Interest income	$	1	$	5	$	32	$	-	$	38
Interest expense	$	946	$	232	$	2	$	-	$	1,180

(1)Unallocated corporate expenses are general corporate overhead expenses not directly attributable to any one of the business segments. These expenses are reported separate from the Company’s identified segments and are included in Selling, General and Administrative expenses on the Company’s condensed consolidated statements of operations.

19

The Company’s Chief Operating Decision Maker does not review assets by segment as part of the financial information provided, and therefore, no asset information is provided in the above table.

Note 14. Subsequent Events

Dividend Declaration

On March 15, 2022, the Company’s Board declared a cash dividend of $0.78 per share payable on April 29, 2022 to shareholders of record on April 15, 2022.

Changes to Executive Leadership and the Board

On March 15, 2022, the Board adopted a resolution to increase the size of the Board from ten to eleven, effective immediately.

On March 16, 2022, the Company announced the (i) retirement of Garry O. Ridge as CEO of the Company, effective August 31, 2022, (ii) the appointment of Steven A. Brass, currently the President and Chief Operating Officer (“COO”) of the Company, as CEO, effective September 1, 2022, and (iii) the appointment of Mr. Brass to the Board, effective March 15, 2022.

Mr. Ridge will remain as an employee of the Company until January 2, 2023, after which he will serve as a consultant to the Company until June 30, 2023, and will remain on the Board of the Company and serve as Chairman, until December 13, 2022.

In connection with Mr. Ridge’s retirement, the Company and Mr. Ridge entered into a Transition and Release Agreement on March 11, 2022 (the “Transition Agreement”) and signed the FY 2022 Restricted Stock Unit Award Agreement (“RSU Agreement”). Pursuant to the Transition Agreement, the Company granted him 5,347 restricted stock units (with a value of $1.0 million) with a grant date of March 17, 2022, which are scheduled to vest on June 30, 2023, subject to certain terms and conditions in the Transition Agreement and/or the RSU Agreement.

The foregoing description of the terms and conditions of the Transition Agreement and the RSU Agreement does not purport to be complete and is qualified in its entirety by reference to the Transition Agreement and the RSU Agreement, which are filed as Exhibit 10(c) and Exhibit 10(d), respectively, included in Part II-Item 6, “Exhibits” and incorporated by reference in this report.

‎

20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used in this report, the terms “we,” “our,” and “us” refer to WD-40 Company and its wholly-owned subsidiaries, unless the context suggests otherwise. Amounts and percentages in tables and discussions may not total due to rounding.

The following information is provided as a supplement to, and should be read in conjunction with, the unaudited condensed consolidated financial statements and notes thereto included in Part I―Item 1 of this Quarterly Report and the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the Securities and Exchange Commission (“SEC”) on October 22, 2021.

In order to show the impact of changes in foreign currency exchange rates on our results of operations, we have included constant currency disclosures, where necessary, in the Overview and Results of Operations sections which follow. Constant currency disclosures represent the translation of our current fiscal year revenues and expenses from the functional currencies of our subsidiaries to U.S. Dollars using the exchange rates in effect for the corresponding period of the prior fiscal year. We use results on a constant currency basis as one of the measures to understand our operating results and evaluate our performance in comparison to prior periods. Results on a constant currency basis are not in accordance with generally accepted accounting principles in the United States of America (“non-GAAP”) and should be considered in addition to, not as a substitute for, results prepared in accordance with GAAP.

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for certain forward-looking statements. This report contains forward-looking statements, which reflect our current views with respect to future events and financial performance. These forward-looking statements are generally identified with words such as “believe,” “expect,” “intend,” “plan,” “could,” “may,” “aim,” “anticipate,” “target,” “estimate” and similar expressions. 

These forward-looking statements include, but are not limited to, discussions about future financial and operating results, including:  growth expectations for maintenance products; expected levels of promotional and advertising spending; anticipated input costs for manufacturing and the costs associated with distribution of our products; plans for and success of product innovation, the impact of new product introductions on the growth of sales; anticipated results from product line extension sales; expected tax rates and the impact of tax legislation and regulatory action; the length and severity of the current COVID-19 pandemic and its impact on the global economy and our financial results; changes in the political conditions or relations between the United States and other nations, the impacts from inflationary trends and supply chain constraints; and forecasted foreign currency exchange rates and commodity prices.  We undertake no obligation to revise or update any forward-looking statements.

Actual events or results may differ materially from those projected in forward-looking statements due to various factors, including, but not limited to, those identified in Part I―Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, and in our Quarterly Reports on Form 10-Q, which may be updated from time to time.

Overview

The Company

WD-40 Company (the “Company”), based in San Diego, California, is a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories and homes around the world. We own a wide range of well-known brands that include maintenance products and homecare and cleaning products: WD-40® Multi-Use Product, WD-40 Specialist®, 3-IN-ONE®, GT85®, 2000 Flushes®, no vac®, 1001®, Spot Shot®, Lava®, Solvol®, X-14® and Carpet Fresh®.

Our products are sold in various locations around the world. Maintenance products are sold worldwide in markets throughout North, Central and South America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold primarily in North America, the United Kingdom (“U.K.”) and Australia. We sell our products primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial distributors and suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike dealers.

21

Highlights

The following summarizes the financial and operational highlights for our business during the six months ended February 28, 2022:

Consolidated net sales increased $28.3 million, or 12%, for the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year. Changes in foreign currency exchange rates had a favorable impact of $2.5 million on consolidated net sales for the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year. Thus, on a constant currency basis, net sales would have increased by $25.8 million, or 11%, from period to period. This favorable impact from changes in foreign currency exchange rates mainly came from our EMEA segment, which accounted for 42% of our consolidated sales for the six months ended February 28, 2022.

Gross profit as a percentage of net sales decreased to 50.6% for the six months ended February 28, 2022 compared to 55.9% for the corresponding period of the prior fiscal year primarily due to increased global supply chain challenges, including the increased cost of raw materials and constraints related to the ongoing COVID-19 pandemic. These ongoing challenges have resulted in increased inflation rates globally. See the Impact of COVID-19 on Our Business section which follows for details.

Consolidated net income decreased $2.8 million, or 7%, for the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year. Changes in foreign currency exchange rates had a favorable impact of $0.5 million on consolidated net income for the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year. Thus, on a constant currency basis, net income would have decreased $3.3 million, or 8%, from period to period.

Diluted earnings per common share for the six months ended February 28, 2022 were $2.75 versus $2.96 in the prior fiscal year period.

Our strategic initiatives and the areas where we will continue to focus our time, talent and resources in future periods include: (i) building a business for the future; (ii) attracting, developing and engaging outstanding tribe members; (iii) striving for operational excellence; (iv) growing WD-40 Multi-Use Product; (v) growing WD-40 Specialist product line; and (vi) expanding and supporting portfolio opportunities that help us grow.

Significant Developments

Impact of COVID-19 on Our Business

Our financial results and operations continue to be impacted by the COVID-19 pandemic that began during our fiscal year 2020. The ongoing COVID-19 pandemic has impacted global economies, the rate of inflation, supply chains, distribution networks and consumer behavior around the world. We have experienced both favorable and unfavorable impacts to our financial results and our operations as a result of the direct and indirect effects of the COVID-19 pandemic. For example, although sales have been negatively impacted at varying times in the regions in which we operate due to health and safety restrictions required by local governmental authorities, those negative sales impacts have generally been more than offset by increased demand for our products as a result of the shift in consumer spending patterns compared to periods before the pandemic. This shift in spending patterns, which has included increased renovation and maintenance activities as well as increased online purchases, contributed to record sales for the Company in fiscal year 2021. However, global supply chain issues have resulted in increased raw material costs and other input costs, as well as significantly higher competition for freight resources and labor constraints within distribution networks, which has also caused increased costs. These increased costs started to negatively impact our gross margin and financial results in our fiscal year 2021. We began to experience more significant negative impacts from this inflationary environment in the first half of fiscal year 2022 resulting in a lower gross margin as compared to the first half of the prior fiscal year.

Some of the increasing supply chain challenges that we have experienced include general aerosol production capacity constraints and competition for such capacity by other companies who utilize the same third-party manufacturers for their aerosol production. Supply chains at many companies globally are being strained due to shortages of certain materials and this is impacting the ability of our third-party manufacturers to procure certain raw materials needed to manufacture our

22

products. These challenges have periodically resulted in us not being able to meet the high level of demand for our products by customers and end-users in certain markets, most significantly those markets in our Americas segment where demand for aerosols has significantly outpaced the available production capacity in the region. We are continuing to actively manage supply chain and transportation disruptions and constraints that have arisen periodically within all three of our business segments, but particularly in the Americas, during the COVID-19 pandemic. We have been actively working on various initiatives with our existing third-party manufacturers and we are also identifying and onboarding new third-party manufacturers. As a result of these initiatives, we are beginning to see increases in the capacity and flexibility of our supply chain and we were more able to meet strong end-user demand during the second quarter of fiscal year 2022. When we onboard new third-party manufacturers, it comes with inherent risks and in the current economic environment, it also potentially comes with higher costs. Although we are not able to estimate the degree of the impact or the costs associated with potential future disruptions within our supply chain and distribution networks, or the costs associated with our initiatives to address these challenges, we believe that the changes we continue to implement as a result of the pandemic will have a positive lasting impact on our ability to better manage any future disruptions. However, some of the additional costs resulting from these recent supply chain constraints, as well as the inflationary environment that is impacting our raw material costs, are expected to unfavorably impact our cost of goods sold for as long as such conditions exist. To offset these unfavorable impacts to gross margin, price increases are being implemented across all of our markets and geographies. It will take time before the full impact of these price increases is reflected in our reported results and it is possible that sales volumes may be impacted unfavorably in the short term as customers and end users adjust to increased sales prices.

Although several vaccines and treatments are authorized for use against COVID-19, these vaccines and treatments are being produced, distributed and accepted at varying rates globally and circumstances continue to evolve with COVID-19 case counts and new variants. The severity and duration of this rapidly evolving pandemic remain uncertain and it is difficult for us to estimate the extent to which the COVID-19 pandemic will impact our financial results and operations in future periods. It is also uncertain how more stable conditions surrounding the pandemic or the end of the pandemic will impact the high levels of renovation and maintenance activities that we have seen by end-users in recent periods. If such activities decrease in future periods, this could adversely impact our financial results.

We have continued to follow a variety of measures to promote the safety and security of our employees, support the communities in which we operate and ensure the availability and functioning of our critical infrastructure. During the pandemic, these measures have included allowing for or requiring remote working arrangements for employees in some regions and the imposition of various travel restrictions. In addition, we continue to develop and monitor plans to support a safe working environment for our employees that includes reentry plans for various office locations in which we operate around the world. These plans vary by region based on the evolving situations within those regions. In connection with these plans, we have put in place our “Work from Where” philosophy to support work-life integration, and enable management and employees to align on where work is completed.

See our risk factors disclosed in Part I―Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021 for information on risks associated with pandemics in general and COVID-19 specifically.

The Impact of Russian Military Action in Ukraine

On February 24, 2022, Russian forces launched significant military action against Ukraine, which has resulted in conflict and disruption in the region. In response to this action taken by Russia, the U.S. and other countries immediately imposed various economic sanctions against Russia. In the event these geopolitical tensions fail to improve or deteriorate further, additional governmental sanctions may be enacted. The direct and indirect impacts of this evolving situation and its effect on global economies in future periods are difficult to predict. We have suspended selling our products to markets in Russia and Belarus beginning in March 2022, which will have an unfavorable impact on our sales in future periods. In addition, we are currently unable to sell our products in Ukraine due to the disruption in the country. Our net sales to the regions that are directly impacted were approximately 3% of consolidated net sales for fiscal year 2021 and approximately 4% of consolidated net sales for the first half of fiscal year 2022. We do not have significant operations in these affected regions other than the distribution and sale of our products, which occurs through marketing distributors.

As a result of this conflict, commodity markets remain subject to heightened levels of uncertainty, especially as they relate to the price of crude oil, which increased significantly in the immediate aftermath of the sanctions against Russia. Increases in crude oil prices unfavorably impact the cost of our products and the transportation of our products. The length and severity

23

of the recent increases in the price of crude oil are highly unpredictable and may unfavorably impact our cost of goods sold for as long as these conditions exist. There is often a delay of one quarter or more before changes in raw material costs impact the cost of products sold due to production and inventory life cycles.

Results of Operations

Three and Six Months Ended February 28, 2022 Compared to Three and Six Months Ended February 28, 2021

Operating Items

The following table summarizes operating data for our consolidated operations (in thousands, except percentages and per share amounts):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Net sales:
Maintenance products	$	121,901	$	102,728	$	19,173		19%	$	247,931	$	217,072	$	30,859		14%
HCCP (1)		8,085		9,177		(1,092)		(12)%		16,801		19,392		(2,591)		(13)%
Total net sales		129,986		111,905		18,081		16%		264,732		236,464		28,268		12%
Cost of products sold		64,468		49,898		14,570		29%		130,744		104,211		26,533		25%
Gross profit		65,518		62,007		3,511		6%		133,988		132,253		1,735		1%
Operating expenses		40,775		41,352		(577)		(1)%		85,185		83,206		1,979		2%
Income from operations	$	24,743	$	20,655	$	4,088		20%	$	48,803	$	49,047	$	(244)		-
Net income	$	19,508	$	17,191	$	2,317		13%	$	38,063	$	40,814	$	(2,751)		(7)%
EPS - diluted	$	1.41	$	1.24	$	0.17		14%	$	2.75	$	2.96	$	(0.21)		(7)%
Shares used in diluted EPS		13,705		13,729		(24)		-		13,805		13,718		87		1%

(1)Homecare and cleaning products (“HCCP”)

Net Sales by Segment

The following table summarizes net sales by segment (in thousands, except percentages):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Americas	$	54,497	$	46,157	$	8,340		18%	$	110,785	$	100,344	$	10,441		10%
EMEA		54,063		49,813		4,250		9%		111,618		104,563		7,055		7%
Asia-Pacific		21,426		15,935		5,491		34%		42,329		31,557		10,772		34%
Total	$	129,986	$	111,905	$	18,081		16%	$	264,732	$	236,464	$	28,268		12%

‎

24

Americas Sales

The following table summarizes net sales by product line for the Americas segment, which includes the U.S., Canada and Latin America (in thousands, except percentages):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Maintenance products	$	50,409	$	41,310	$	9,099		22%	$	102,393	$	89,812	$	12,581		14%
HCCP		4,088		4,847		(759)		(16)%		8,392		10,532		(2,140)		(20)%
Total	$	54,497	$	46,157	$	8,340		18%	$	110,785	$	100,344	$	10,441		10%
% of consolidated net sales		42%		41%						42%		43%
CC Net sales - non-GAAP (1)	$	54,678	$	46,157	$	8,521		18%	$	110,471	$	100,344	$	10,127		10%

(1)Current fiscal year constant currency (“CC”) net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior period actual net sales.

Americas Sales – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales of maintenance products in the Americas segment increased due to the following:

United States (“U.S.”) sales increased $7.6 million, or 26%, primarily due to increased sales of WD-40 Multi-Use Product and WD-40 Specialist. While the U.S. has continued to experience a high level of demand for its maintenance products after the onset of the COVID-19 pandemic, it has also continued to experience significant supply chain constraints as a result of the pandemic in both periods. However, adjustments we have made in our supply chain to increase the production capacity of our most significant products improved the availability of these products from period to period. WD-40 Multi-Use Product sales increased by $4.7 million, or 19%, primarily due to increased product availability and price increases that went into effect in the first quarter of this fiscal year. In addition, sales during the comparable period in the prior year were negatively impacted by severe winter storms that temporarily halted product delivery in the U.S., with no comparable event during the current fiscal year. WD-40 Specialist products are sourced at certain third-party manufacturers that were more significantly impacted by the various global supply chain constraints experienced over the last several quarters. WD-40 Specialist sales increased by $3.1 million, or 125%, primarily due to the improvements in these supply chain conditions which significantly improved product availability in the second quarter of this year, as well as price increases.

Latin America sales increased $1.5 million, or 18%, primarily due to successful promotional programs and increased product availability in certain of our Latin America markets, as well as favorable impacts from sales price increases that went into effect in November 2021 in our distributor markets. In addition, the continued momentum from the shift in the Mexico market from a distributor model to the direct model that we made in late fiscal year 2020 favorably impacted sales period over period as a result of new distribution and continued growth of the base business. In addition, sales in Mexico increased due to customers purchasing product in advance of a price increase that went into effect in February 2022.

Canada sales remained relatively consistent period over period. 

Net sales of HCCP brands in the Americas decreased primarily due to the following:

Challenges in our Americas supply chain, primarily in the U.S., resulted in decreased product availability and lower net sales for most HCCP brands. While we have been actively working to increase the capacity and flexibility of our supply chain in recent periods, the adjustments we have made to date have been more heavily focused on our most significant products, primarily our maintenance products.

While each of our homecare and cleaning products have continued to generate positive cash flows, we have experienced flat or slightly decreased sales for many of these products in recent periods.

25

For the three months ended February 28, 2022, 74% of sales came from the U.S., and 26% of sales came from Canada and Latin America combined compared to the distribution for the three months ended February 28, 2021 when 72% of sales came from the U.S., and 28% of sales came from Canada and Latin America.

Americas Sales – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales of maintenance products in the Americas segment increased due primarily to the following:

U.S. sales increased $7.1 million, or 11%, due to increased sales of WD-40 Multi-Use Product and WD-40 Specialist of $6.2 million, or 11%, and $1.8 million, or 25%, respectively. These increases for both products were primarily due to price increases that went into effect in the first quarter of this fiscal year and supply chain improvements which resulted in increased product availability as discussed above in the section for the three months ended February 28, 2022. These increases were slightly offset by lower 3-IN-ONE sales of $0.9 million, or 23%, due to decreased product availability as a result of the supply chain constraints we have experienced at our third-party manufacturers who produce this product.

Latin America sales increased $5.5 million, or 31%, primarily due to higher sales throughout many markets in the region, including in our direct market in Mexico. Increased sales were primarily due to many distributor customers and Mexico direct customers purchasing product in advance of price increases that went into effect in the first half of this fiscal year. In addition, sales were favorably impacted by increased product availability, successful promotional programs, price increases and the continued momentum in our direct market in Mexico, as discussed above in the section for the three months ended February 28, 2022.

Canada sales remained relatively consistent period over period. 

Net sales of HCCP in the Americas decreased due to the following:

Challenges in our Americas supply chain negatively impacted net sales for these products, as discussed above in the section for the three months ended February 28, 2022.

For the six months ended February 28, 2022, 72% of sales came from the U.S., and 28% of sales came from Canada and Latin America combined, compared to the distribution for the six months ended February 28, 2021 when 75% of sales came from the U.S., and 25% of sales came from Canada and Latin America.

EMEA Sales

The following table summarizes net sales by product line for the EMEA segment, which includes Europe, the Middle East, Africa and India (in thousands, except percentages):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Maintenance products	$	52,093	$	47,736	$	4,357		9%	$	107,536	$	100,114	$	7,422		7%
HCCP		1,970		2,077		(107)		(5)%		4,082		4,449		(367)		(8)%
Total (1)	$	54,063	$	49,813	$	4,250		9%	$	111,618	$	104,563	$	7,055		7%
% of consolidated net sales		42%		45%						42%		44%
CC Net sales - non-GAAP (2)	$	54,617	$	49,813	$	4,804		10%	$	109,695	$	104,563	$	5,132		5%

(1)While the Company’s reporting currency is the U.S. Dollar, the functional currency of our U.K. subsidiary, the entity in which the EMEA results are generated, is Pound Sterling. Although the functional currency of this subsidiary is Pound Sterling, approximately 50% of its sales are generated in Euro and 15-20% are generated in U.S. Dollar. As a result, the Pound Sterling sales and earnings for the EMEA segment can be negatively or positively impacted from period to period upon translation from these currencies depending on whether the Euro and U.S. Dollar are weakening or strengthening against the Pound Sterling.

(2)Current fiscal year constant currency net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior period actual net sales.

26

The countries and regions in Europe where we sell through a direct sales force include the U.K., Italy, France, Iberia (which includes Spain and Portugal) and the Germanics sales region (which includes Austria, Denmark, Switzerland, Belgium and the Netherlands). The regions in the EMEA segment where we sell through local distributors include the Middle East, Africa, India, Eastern and Northern Europe.

EMEA Sales – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales increased in the EMEA segment primarily due to the following:

Direct Markets – EMEA (65% of net sales QTD FY2022 vs 67% QTD FY2021)

Direct market sales increased $2.1 million, or 6%, primarily due to increased sales of WD-40 Multi-Use Product in all direct markets, with the exception of the U.K..

Sales in the EMEA direct markets, excluding the U.K., increased $3.1 million, or 12%. These increases were primarily due to the favorable impacts of price increases that were implemented over the last twelve months, as well as many customers purchasing product in advance of additional price increases that will occur during the third quarter of fiscal year 2022.

These increases were partially offset by lower sales in the U.K., which were down $1.0 million, or 12%, primarily due to a lower level of promotional programs that were conducted period over period, which was slightly offset by the favorable impacts of sales price increases.

Sales in our direct markets were unfavorably impacted by the weakening of the Pound Sterling, the functional currency of our U.K. subsidiary, against the U.S. Dollar. In addition, sales in our direct markets were unfavorably impacted by the weakening of the Euro against the Pound Sterling from period to period for sales generated in our Euro-based direct markets.

Distributor Markets – EMEA (35% of net sales QTD FY2022 vs 33% QTD FY2021)

Distributor market sales increased $2.2 million, or 13%, primarily due to increased sales of maintenance products in Russia, which were up $0.7 million, as well as higher sales in Turkey, Poland, and the Czech Republic, each of which was up $0.5 million. See The Impact of Russian Military Action in Ukraine described in the “Significant Developments” section above for further information regarding the suspension of our sales to Russian markets.

These increases were primarily due to the timing of customer orders from period to period, price increases and distributors purchasing product in advance of additional price increases that will occur during the third quarter of fiscal year 2022.

EMEA Sales – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales increased in the EMEA segment due to the following drivers:

Direct Markets – EMEA (64% of net sales YTD FY2022 vs 66% YTD FY2021)

Direct markets increased $3.1 million, or 5%, primarily due to increased sales of WD-40 Multi-Use Product and WD-40 Specialist in all direct markets, with the exception of the U.K.

Sales in the EMEA direct markets, excluding the U.K. increased $5.6 million, or 11%, primarily due to new distribution and successful promotional programs during the first quarter of fiscal year 2022, as well as the favorable impacts of price increases, as discussed above in the section for the three months ended February 28, 2022.

These increases were partially offset by lower sales in the U.K., which were down $2.5 million, or 14%, primarily due to a lower level of promotional programs that were conducted period over period and the timing of customer orders, which were slightly offset by sales price increases.

Sales in our direct markets benefited from the strengthening of the Pound Sterling, the functional currency of our U.K. subsidiary, against the U.S. Dollar. However, these benefits were more than offset in the opposite direction as a result of the weakening of the Euro against the Pound Sterling from period to period for sales generated in our Euro-based direct markets.

‎

27

Distributor Markets – EMEA (36% of net sales YTD FY2022 vs 34% YTD FY2021)

Distributor markets increased $4.0 million, or 11%, primarily due to increased sales of the WD-40 Multi-Use Product in Poland, Russia and the Czech Republic, which were up $1.5 million, $1.3 million and $1.0 million, respectively.

Increased sales in the distributor markets were primarily due to new distribution, successful promotional programs and favorable changes in foreign currency exchange rates during the first quarter of fiscal year 2022, as well as other impacts discussed above in the section for the three months ended February 28, 2022.

Asia-Pacific Sales

The following table summarizes net sales by product line for the Asia-Pacific segment, which includes Australia, China and other countries in the Asia region (in thousands, except percentages):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Maintenance products	$	19,399	$	13,682	$	5,717		42%	$	38,002	$	27,146	$	10,856		40%
HCCP		2,027		2,253		(226)		(10)%		4,327		4,411		(84)		(2)%
Total	$	21,426	$	15,935	$	5,491		34%	$	42,329	$	31,557	$	10,772		34%
% of consolidated net sales		16%		14%						16%		13%
CC Net sales - non-GAAP (1)	$	21,579	$	15,935	$	5,644		35%	$	42,035	$	31,557	$	10,478		33%

(1)Current fiscal year constant currency (“CC”) net sales translated at the foreign currency exchange rates in effect for the corresponding period of the prior fiscal year, compared to prior period actual net sales.

Asia-Pacific Sales – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales in the Asia-Pacific segment increased primarily due to the following:

Asia distributor markets sales increased $3.8 million, or 64%, primarily due to higher sales of WD-40 Multi-Use Product as a result of distributors purchasing product in advance of a price increase that went into effect in March 2022, as well as the timing of customer orders and promotional programs from period to period. In addition, sales increased due to the continued easing of COVID-19 lockdown measures and restrictions compared to the corresponding period of the prior fiscal year. These reduced lockdown measures positively impacted economic conditions during the second quarter of fiscal year 2022 and resulted in increased demand and higher sales in most countries.

China sales increased $2.0 million, or 42%, primarily due to a higher level of promotional activities as well as customers purchasing product in advance of a price increase that went into effect during the second quarter of fiscal year 2022.

Australia sales decreased $0.3 million, or 5%, primarily due to decreased sales of homecare and cleaning products, which were down $0.2 million, or 10%.

Asia-Pacific Sales – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Net sales in the Asia-Pacific segment increased due to the following drivers:

Sales in the Asia distributor markets increased $6.3 million, or 49%, primarily due to the various impacts discussed above in the section for the three months ended February 28, 2022.

Sales in China increased $4.4 million, or 54%, primarily due to a higher level of promotional activities as well as price increases that went into effect during the second quarter of fiscal year 2022. In addition, sales increased due to the timing of customer orders from period to period.

Australia sales remained relatively consistent period over period. 

28

Gross Profit

The following general information regarding the timing and nature of our product costs is important when assessing fluctuations in our gross margin from period to period:

There is often a delay of one quarter or more before changes in raw materials, such as specialty chemicals used in the formulation of our products, impact cost of products sold due to production and inventory life cycles;

In general, the timing of advertising, promotional and other discounts may cause fluctuations in gross margin from period to period. Advertising, promotional and other discounts that are given to our customers are recorded as a reduction to sales, whereas advertising and sales promotional costs associated with promotional activities that we pay to third parties are recorded as advertising and sales promotion expenses;

In the EMEA segment, the majority of our cost of goods sold is denominated in Pound Sterling whereas sales are generated in Pound Sterling, Euro and the U.S. Dollar. The strengthening or weakening of the Euro and U.S. Dollar against the Pound Sterling may result in foreign currency related changes to the gross margin percentage in the EMEA segment from period to period; and

Our gross profit and gross margin may not be comparable to those of other consumer product companies, since some of these companies include all costs related to distribution of their products in cost of products sold, whereas we exclude the portion associated with amounts paid to third parties for shipment to our customers from our distribution centers and contract manufacturers and include these costs in selling, general and administrative expenses. These costs totaled $4.7 million and $3.5 million for the three months ended February 28, 2022 and 2021, respectively, and $9.5 million and $7.7 million for the six months ended February 28, 2022 and 2021, respectively.

For further information pertaining to recent trends and economic conditions affecting gross margin, please see the section titled “Significant Developments”.

The following table summarizes gross margin and gross profit (in thousands, except percentages):

	Three Months Ended February 28,							Six Months Ended February 28,
	2022		2021		Change from ‎Prior Year			2022		2021		Change from ‎Prior Year
Gross profit	$	65,518	$	62,007	$	3,511		$	133,988	$	132,253	$	1,735
Gross margin		50.4%		55.4%		(500)	bps (1)		50.6%		55.9%		(530)	bps (1)

(1)Basis points (“bps”) change in gross margin.

Gross Margin - Three Months Ended – February 28, 2022 Compared to February 28, 2021

Gross margin decreased 500 bps primarily due to the following unfavorable impacts, partially offset by favorable impacts:

1010
Unfavorable Impacts	Favorable Impacts
(370) bps - Higher costs of specialty chemicals used in the formulation of our products. (110) bps - Higher warehousing, distribution and freight costs associated with supply chain constraints as a result of the ongoing COVID-19 pandemic, the worsening inflationary environment and initiatives to increase production capacity while these constraints exist.  (80) bps - Higher filling fees paid to our third-party contract manufacturers, primarily in the Americas segment.  (60) bps - Changes in foreign currency exchange rates in the EMEA segment.  (60) bps - Higher miscellaneous costs associated with inventory and overhead in the Americas segment as well as unfavorable product mix.	200 bps - Sales price increases implemented during the last 12 months in all three segments.

‎

29

Gross Margin - Six Months Ended – February 28, 2022 Compared to February 28, 2021

Gross margin decreased 530 bps primarily due to the following unfavorable impacts, partially offset by favorable impacts:

1010
Unfavorable Impacts	Favorable Impacts
(380) bps - Higher costs of specialty chemicals used in the formulation of our products. (130) bps - Higher warehousing, distribution and freight costs associated with supply chain constraints as a result of the ongoing COVID-19 pandemic, the worsening inflationary environment and initiatives to increase production capacity while these constraints exist.  (80) bps - Higher filling fees paid to our third-party contract manufacturers, primarily in the Americas segment.  (60) bps - Changes in foreign currency exchange rates in the EMEA segment.	160 bps - Sales price increases implemented during the last 12 months all three segments.

Selling, General and Administrative (“SG&A”) Expenses

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
(in thousands)	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
SG&A expenses	$	34,819	$	35,478	$	(659)		(2)%	$	73,242	$	71,455	$	1,787		3%
% of net sales		26.8%		31.7%						27.7%		30.2%

SG&A Expenses – Three Months Ended – February 28, 2022 Compared to February 28, 2021

The decrease in SG&A expenses was primarily due to lower employee-related costs, which decreased by $1.9 million due to lower incentive compensation accruals of $3.2 million, which were partially offset by increased headcount and annual compensation increases. The lower incentive compensation accruals are based on our most current forecast for fiscal year 2022 and we are projecting a lower level of achievement than the prior year for such compensation. In addition, lower miscellaneous costs also decreased SG&A expenses by $0.5 million from period to period. These decreases were significantly offset by freight cost increases of $1.2 million due to higher sales levels as well as carrier price increases associated with supply chain constraints and limited capacity in the global distribution networks. In addition, travel and meeting expense increased $0.5 million due to the reduction in travel restrictions related to COVID-19.

SG&A Expenses – Six Months Ended – February 28, 2022 Compared to February 28, 2021

The increase in SG&A expenses from period to period was due to a variety of factors. Freight costs increased $1.8 million due to higher sales levels as well as carrier price increases associated with supply chain constraints and limited capacity in the global distribution networks. Additionally, travel and meeting expense increased $1.1 million due to the reduction in travel restrictions related to COVID-19. Changes in foreign currency exchange rates from period to period also resulted in an increase of $0.5 million in SG&A expenses. These increases to SG&A expenses were offset by lower employee-related costs of $1.6 million, primarily due to lower incentive compensation accruals of $4.0 million, which were partially offset by increased headcount and annual compensation increases.

Note that we continued our research and development investment, the majority of which is associated with our maintenance products, in support of our focus on innovation and renovation of our products. Research and development costs were $1.3 million for both the three months ended February 28, 2022 and 2021, and $2.6 million and $2.9 million for the six months ended February 28, 2022 and 2021, respectively. Our research and development team engages in consumer research, product development, current product improvements and testing activities. This team leverages its development capabilities by collaborating with a network of outside resources including our current and prospective third-party contract manufacturers. The level and types of expenses incurred within research and development can vary from period to period depending upon the types of activities being performed.

30

Advertising and Sales Promotion (“A&P”) Expenses

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
(in thousands)	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
A&P expenses	$	5,596	$	5,512	$	84		2%	$	11,220	$	11,031	$	189		2%
% of net sales		4.3%		4.9%						4.2%		4.7%

A&P Expenses – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Although, A&P expenses increased slightly from period to period, A&P expenses as a percentage of net sales decreased primarily due to a lower level of promotional programs and marketing support in the Americas segment. Changes in foreign currency exchange rates did not have a significant impact on A&P expenses period over period.

As a percentage of net sales, A&P expenses may fluctuate period to period based upon the type of marketing activities we employ and the period in which the costs are incurred. Total promotional costs recorded as a reduction to sales was $6.4 million and $5.9 million for three months ended February 28, 2022 and 2021, respectively. Therefore, our total investment in A&P activities totaled $12.0 million and $11.4 million for the three months ended February 28, 2022 and 2021, respectively.

A&P Expenses – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Although A&P expenses increased slightly from period to period, A&P expenses as a percentage of net sales decreased primarily due to a lower level of promotional programs and marketing support in the Americas segment. Changes in foreign currency exchange rates did not have a significant impact on A&P expenses period over period.

Total promotional costs recorded as a reduction to sales was $13.3 million and $11.7 million for six months ended February 28, 2022 and 2021, respectively. Therefore, our total investment in A&P activities totaled $24.5 million and $22.7 million for the six months ended February 28, 2022 and 2021, respectively.

Income from Operations by Segment

The following table summarizes income from operations by segment (in thousands, except percentages):

	Three Months Ended February 28,								Six Months Ended February 28,
					Change from ‎Prior Year								Change from ‎Prior Year
	2022		2021		Dollars		Percent		2022		2021		Dollars		Percent
Americas	$	11,217	$	10,356	$	861		8%	$	23,234	$	24,982	$	(1,748)		(7)%
EMEA		13,715		14,176		(461)		(3)%		27,928		31,919		(3,991)		(13)%
Asia-Pacific		7,925		5,188		2,737		53%		15,227		10,247		4,980		49%
Unallocated corporate		(8,114)		(9,065)		951		10%		(17,586)		(18,101)		515		3%
Total	$	24,743	$	20,655	$	4,088		20%	$	48,803	$	49,047	$	(244)		-

Americas

Americas Operating Income – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the Americas increased to $11.2 million, up $0.9 million, or 8%, primarily due to an $8.3 million increase in sales, partially offset by a lower gross margin. Gross margin for the Americas segment decreased from 53.5% to 46.7% primarily due to increases in the costs of petroleum-based specialty chemicals. In addition, gross margin was

31

unfavorably impacted by increased warehousing, distribution and freight costs and higher costs at our third-party manufacturers due to supply chain constraints and inflationary impacts as a result of the direct and indirect effects of the COVID-19 pandemic. These unfavorable impacts to gross margin were partially offset by the favorable impacts of price increases that were implemented during the first half of fiscal year 2022. Although operating expenses remained relatively constant from period to period, there were various items that offset each other from period to period. Operating expenses associated with higher outbound freight costs as a result of increased sales and higher freight rates, increased headcount and salaries, and higher travel and meeting expenses were completely offset by lower accrued incentive compensation and lower A&P expenses from period to period. Operating income as a percentage of net sales decreased from 22.4% to 20.6% period over period.

Americas Operating Income – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the Americas decreased to $23.2 million, down $1.7 million, or 7%, primarily due to a lower gross margin and higher operating expenses, partially offset by a $10.4 million increase in sales. Gross margin for the Americas segment decreased from 53.9% to 47.7% primarily due to increases in the costs of petroleum-based specialty chemicals. In addition, gross margin was unfavorably impacted by increased warehousing, distribution and freight costs and higher costs at our third-party manufacturers due to supply chain constraints and inflationary impacts as a result of the direct and indirect effects of the COVID-19 pandemic, as well as increases in the discounts provided to customers. These unfavorable impacts to gross margin were partially offset by the combined favorable impacts of price increases that were implemented during the first half of fiscal year 2022 as well as increased supplier rebates primarily as a result of higher aerosol can purchase volumes from period to period. Operating expenses increased period over period primarily due to higher outbound freight costs as a result of increased sales and higher freight rates, increased headcount and salaries, and higher travel and meeting expenses, which were partially offset by lower accrued incentive compensation and lower A&P expenses. Operating income as a percentage of net sales decreased from 24.9% to 21.0% period over period.

EMEA

EMEA Operating Income – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the EMEA segment decreased to $13.7 million, down $0.5 million, or 3%, primarily due to a lower gross margin and an increase in operating expenses, partially offset by a $4.2 million increase in sales. Gross margin for the EMEA segment decreased from 56.7% to 52.0% period over period primarily due to increased costs of petroleum-based specialty chemicals and aerosol cans as well as unfavorable changes in foreign currency exchange rates. These unfavorable impacts to gross margin were partially offset by price increases that were implemented over the last twelve months. Operating expenses increased $0.3 million period over period primarily due to higher A&P expenses, increased headcount and salaries, and higher travel and meeting expenses, which were significantly offset by lower accrued incentive compensation during the period. Operating income as a percentage of net sales decreased from 28.5% to 25.4% period over period.

EMEA Operating Income – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the EMEA segment decreased to $27.9 million, down $4.0 million, or 13%, primarily due to a lower gross margin and an increase in operating expenses, partially offset by a $7.1 million increase in sales. Gross margin for the EMEA segment decreased from 57.6% to 51.8% period over period primarily due to increased costs of petroleum-based specialty chemicals and aerosol cans as well as unfavorable changes in foreign currency exchange rates. In addition, gross margin was also unfavorably impacted by increased warehousing, distribution and freight costs from period to period due to supply chain constraints and inflationary impacts as a result of the direct and indirect effects of the COVID-19 pandemic. These unfavorable impacts to gross margin were partially offset by price increases that were implemented over the last twelve months, as well as decreases to advertising, promotional, and other discounts given to our customers from period to period. Operating expenses increased $1.5 million period over period primarily due to higher A&P expenses, increased headcount and salaries, and higher travel and meeting expenses, which were partially offset by lower accrued incentive compensation. Operating income as a percentage of net sales decreased from 30.5% to 25.0% period over period.

‎

32

Asia-Pacific

Asia-Pacific Operating Income – Three Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the Asia-Pacific segment increased to $7.9 million, up $2.7 million, or 53%, primarily due to a $5.5 million increase in sales, partially offset by a lower gross margin. Gross margin for the Asia-Pacific segment decreased from 56.9% to 55.9% period over period primarily due to increases to the cost of petroleum-based specialty chemicals and aerosol cans from period to period. These unfavorable impacts to gross margin were partially offset by price increases that were implemented during the first half of fiscal year 2022, as well as decreases in advertising, promotional, and other discounts given to our customers from period to period. Operating expenses remained relatively constant from period to period. Operating income as a percentage of net sales increased from 32.6% to 37.0% period over period.

Asia-Pacific Operating Income – Six Months Ended – February 28, 2022 Compared to February 28, 2021

Income from operations for the Asia-Pacific segment increased to $15.2 million, up $5.0 million, or 49%, primarily due to a $10.8 million increase in sales, partially offset by a lower gross margin and increased operating expenses. Gross margin for the Asia-Pacific segment decreased from 56.8% to 55.2% period over period primarily due to increases to the cost of petroleum-based specialty chemicals and aerosol cans from period to period. These unfavorable impacts to gross margin were partially offset by price increases that were implemented during the first half of fiscal year 2022, as well as decreases to advertising, promotional, and other discounts given to our customers from period to period. Operating expenses increased $0.5 million from period to period primarily due to higher A&P expenses and increased headcount and salaries, which were partially offset by lower accrued incentive compensation. Operating income as a percentage of net sales increased from 32.5% to 36.0% period over period.

Non-Operating Items

The following table summarizes non-operating income and expenses for our consolidated operations (in thousands):

	Three Months Ended February 28,						Six Months Ended February 28,
	2022		2021		Change		2022		2021		Change
Interest income	$	21	$	19	$	2	$	46	$	38	$	8
Interest expense	$	613	$	610	$	3	$	1,233	$	1,180	$	53
Other income (expense), net	$	252	$	151	$	101	$	(77)	$	330	$	(407)
Provision for income taxes	$	4,895	$	3,024	$	1,871	$	9,476	$	7,421	$	2,055

Interest Income

Interest income was not significant during the three and six months ended February 28, 2022 and 2021.

Interest Expense

Interest expense was relatively constant during the three and six months ended February 28, 2022 and 2021.

Other Income (Expense), Net

Other income (expense), net was not significant during the three and six months ended February 28, 2022 and 2021.

Provision for Income Taxes

The provision for income taxes was 20.1% and 15.0% of income before income taxes for the three months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to a non-recurring benefit received in the prior year from the settlement of stock-based equity awards.

‎

33

The provision for income taxes was 19.9% and 15.4% of income before income taxes for the six months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to non-recurring benefits received in the prior year from stock-based compensation, coupled with an increase in performance-based compensation that is not deductible for tax purposes in the current fiscal year.

Net Income

Net income was $19.5 million, or $1.41 per common share on a fully diluted basis, for the three months ended February 28, 2022 compared to $17.2 million, or $1.24 per common share on a fully diluted basis, for the corresponding period of the prior fiscal year. Changes in foreign currency exchange rates did not have a significant impact on consolidated net income for the three months ended February 28, 2022 compared to the corresponding period of the prior fiscal year.

Net income was $38.1 million, or $2.75 per common share on a fully diluted basis, for the six months ended February 28, 2022 compared to $40.8 million, or $2.96 per common share on a fully diluted basis, for the corresponding period of the prior fiscal year. Changes in foreign currency exchange rates had a favorable impact of $0.5 million on consolidated net income for the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year. Thus, on a constant currency basis, net income would have decreased $3.3 million, or 8%, from period to period.

Performance Measures and Non-GAAP Reconciliations

In managing our business operations and assessing our financial performance, we supplement the information provided by our financial statements with certain non-GAAP performance measures. These performance measures are part of our current 55/30/25 business model, which includes gross margin, cost of doing business, and earnings before interest, income taxes, depreciation and amortization (“EBITDA”), the latter two of which are non-GAAP performance measures. Cost of doing business is defined as total operating expenses less amortization of definite-lived intangible assets, impairment charges related to intangible assets and depreciation in operating departments, and EBITDA is defined as net income (loss) before interest, income taxes, depreciation and amortization. We target our gross margin to be at or above 55% of net sales, our cost of doing business to be at 30% of net sales, and our EBITDA to be above 25% of net sales. Results for these performance measures may vary from period to period depending on various factors, including economic conditions and our level of investment in activities for the future such as those related to quality assurance, regulatory compliance, and intellectual property protection in order to safeguard our WD-40 brand. The targets for these performance measures are long-term in nature, particularly those for cost of doing business and EBITDA, and we expect to make progress towards achieving them over time.

The following table summarizes the results of these performance measures for the periods presented:

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Gross margin - GAAP		50%		55%		51%		56%
Cost of doing business as a percentage
of net sales - non-GAAP		30%		36%		31%		34%
EBITDA as a percentage of net sales - non-GAAP (1)		21%		20%		20%		22%

(1)Percentages may not aggregate to EBITDA percentage due to rounding and because amounts recorded in other income (expense), net on our consolidated statement of operations are not included as an adjustment to earnings in the EBITDA calculation.

We use the performance measures above to establish financial goals and to gain an understanding of our comparative performance from period to period. We believe that these measures provide our shareholders with additional insights into the Company’s results of operations and how we run our business. The non-GAAP financial measures are supplemental in nature and should not be considered in isolation or as alternatives to net income, income from operations or other financial information prepared in accordance with GAAP as indicators of the Company’s performance or operations. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. Reconciliations of these non-GAAP financial measures to our financial statements as prepared in accordance with GAAP are as follows:

34

Cost of Doing Business (in thousands, except percentages)

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Total operating expenses - GAAP	$	40,775	$	41,352	$	85,185	$	83,206
Amortization of definite-lived intangible assets		(360)		(362)		(723)		(720)
Depreciation (in operating departments)		(1,112)		(1,077)		(2,210)		(2,119)
Cost of doing business	$	39,303	$	39,913	$	82,252	$	80,367
Net sales	$	129,986	$	111,905	$	264,732	$	236,464
Cost of doing business as a percentage
of net sales - non-GAAP		30%		36%		31%		34%

EBITDA (in thousands, except percentages)

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Net income - GAAP	$	19,508	$	17,191	$	38,063	$	40,814
Provision for income taxes		4,895		3,024		9,476		7,421
Interest income		(21)		(19)		(46)		(38)
Interest expense		613		610		1,233		1,180
Amortization of definite-lived intangible assets		360		362		723		720
Depreciation		1,736		1,396		3,359		2,738
EBITDA	$	27,091	$	22,564	$	52,808	$	52,835
Net sales	$	129,986	$	111,905	$	264,732	$	236,464
EBITDA as a percentage of net sales - non-GAAP		21%		20%		20%		22%

Liquidity and Capital Resources

Overview

Our financial condition and liquidity remain strong. Although there continues to be uncertainty related to the anticipated impact of the current COVID-19 pandemic on our future results, we believe our efficient business model and the steps that we have taken position us to manage our business through this crisis as it continues to unfold. We continue to manage all aspects of our business including, but not limited to, monitoring our liquidity, the financial health of our customers, suppliers and other third-party relationships, implementing gross margin enhancement strategies and developing new opportunities for growth.

Our principal sources of liquidity are our existing cash and cash equivalents, as well as cash generated from operations and cash currently available from our existing unsecured revolving credit facility under the Credit Agreement with Bank of America. We use proceeds of the revolving credit facility primarily for our general working capital needs. We also hold borrowings under the Note Agreement. See Note 7 – Debt for additional information on these agreements.

We have historically held a balance of outstanding draws on our line of credit in either U.S. Dollars in the Americas segment, or in Euros and Pound Sterling in the EMEA segment. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates. We regularly convert many of our draws on our line of credit to new draws with new maturity dates and interest rates. We have the ability to refinance any draws under the line of credit with successive short-term borrowings through the September 30, 2025 maturity date of the Credit Agreement. Outstanding draws for which we have the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million of the outstanding balance under our line of credit resides in the EMEA segment and is denominated in Euros and Pound Sterling and classified long-term, whereas $1.2 million is denominated in U.S. Dollar and classified as short-term. In the United States, we held $68.8 million in fixed rate long-term borrowings as of February 28, 2022, consisting of senior notes under our Note

35

Agreement. We paid $0.4 million in principal payments on our Series A Notes during the first half of fiscal year 2022. There were no other letters of credit outstanding or restrictions on the amount available on our line of credit or notes. Per the terms of both the Note Agreement and the Credit Agreement, our consolidated leverage ratio cannot be greater than three and a half to one and our consolidated interest coverage ratio cannot be less than three to one. See Note 7 – Debt for additional information on these financial covenants. At February 28, 2022, we were in compliance with all material debt covenants. We continue to monitor our compliance with all debt covenants and, at the present time, we believe that the likelihood of being unable to satisfy all material covenants is remote. At February 28, 2022, we had a total of $43.3 million in cash and cash equivalents. We do not foresee any ongoing issues with repaying our borrowings and we closely monitor the use of this credit facility.

We believe that our future cash from domestic and international operations, together with our access to funds available under our unsecured revolving credit facility, will provide adequate resources to fund short-term and long-term operating requirements, capital expenditures, dividend payments, acquisitions, new business development activities and share repurchases. On October 12, 2021, our Board of Directors approved a new share repurchase plan. Under the plan, which became effective on November 1, 2021, we are authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023, of which $56.8 million remains available for the repurchase of common shares at February 28, 2022.

Cash Flows

The following table summarizes our cash flows by category for the periods presented (in thousands):

	Six Months Ended February 28,
	2022		2021		Change
Net cash provided by operating activities	$	4,083	$	42,510	$	(38,427)
Net cash used in investing activities		(3,571)		(7,366)		3,795
Net cash provided by used in financing activities		(42,267)		(20,311)		(21,956)
Effect of exchange rate changes on cash and cash equivalents		(884)		1,086		(1,970)
Net (decrease) increase in cash and cash equivalents	$	(42,639)	$	15,919	$	(58,558)

Operating Activities

Net cash provided by operating activities decreased $38.4 million to $4.1 million for the six months ended February 28, 2022 from $42.5 million for the corresponding period of the prior fiscal year. Cash flows from operating activities depend heavily on operating performance and changes in working capital. Our primary source of operating cash flows for the six months ended February 28, 2022 was net income of $38.1 million, which decreased approximately $2.8 million from period to period. The change in our working capital, which decreased net cash provided by operating activities was primarily attributable to increases in inventory in the Americas segment from period to period. This increase in inventory was due to deliberate actions we took to stock certain raw materials and finished goods given the current challenges within supply chain, as well as the higher carrying value of inventory due to higher raw material costs and other input costs from period to period. Net cash provided by operating activities was further decreased due to higher earned incentive payouts in the first quarter of fiscal year 2022 compared to the same period of the prior fiscal year as well as lower level of earned incentive accruals from period to period. In addition, increases in trade accounts receivable balances, primarily in the United Kingdom, decreased net cash provided by operating activities during the six months ended February 28, 2022 compared to the corresponding period of the prior fiscal year as a result of increased sales and the timing of payments from customers.

Investing Activities

Net cash used in investing activities decreased $3.8 million to $3.6 million for the six months ended February 28, 2022 from $7.4 million for the corresponding period of the prior fiscal year, primarily due to a lower level of manufacturing-related capital expenditures within the United States and the United Kingdom from period to period. Capital expenditures during fiscal years 2021 and 2022 were primarily related to manufacturing equipment, some of which is still under construction, and will be located at our third-party manufacturers in the United States and the United Kingdom once completed.

‎

36

Financing Activities

Net cash used by financing activities increased $22.0 million to $42.3 million for the six months ended February 28, 2022 from $20.3 million for the corresponding period of the prior fiscal year. This change was primarily due to the resumption of treasury stock purchases in November 2021, resulting in increased treasury stock purchases of $18.2 million. In addition, increases in dividends paid to our shareholders of $2.2 million and increases in shares withheld to cover taxes on conversion of equity rewards of $0.8 million resulted in higher cash outflows from period to period. Additionally, in the first half of fiscal year 2021, we repaid $50.0 million of borrowings outstanding under our line of credit using $52.0 million in proceeds that we received from the issuance and sale of senior notes during the quarter. This net borrowing activity resulted in a $2.0 million cash inflow during the first half of fiscal year 2021 compared to $1.2 million in net proceeds from our revolving credit facility during the second quarter of fiscal year 2022.

Effect of Exchange Rate Changes

All of our foreign subsidiaries currently operate in currencies other than the U.S. Dollar and a significant portion of our consolidated cash balance is denominated in these foreign functional currencies, particularly at our U.K. subsidiary, which operates in Pound Sterling. As a result, our cash and cash equivalents balances are subject to the effects of the fluctuations in these functional currencies against the U.S. Dollar at the end of each reporting period. The net effect of exchange rate changes on cash and cash equivalents, when expressed in U.S. Dollar terms, was a decrease in cash of $0.9 million for the six months ended February 28, 2022 as compared to an increase in cash of $1.1 million for the six months ended February 28, 2021. These changes were primarily due to fluctuations in various foreign currency exchange rates from period to period, but the majority is related to the fluctuations in the Pound Sterling against the U.S. Dollar.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements as defined by Item 303(a)(4)(ii) of Regulation S-K.

Commercial Commitments

We have ongoing relationships with various third-party suppliers (contract manufacturers) that manufacture our products and third-party distribution centers which warehouse and ship our products to customers. The contract manufacturers maintain title and control of certain raw materials and components, materials utilized in finished products, and of the finished products themselves until shipment to our customers or third-party distribution centers in accordance with agreed upon shipment terms. Although we have definitive minimum purchase obligations in the contract terms with certain of our contract manufacturers, when such obligations have been included, they have either been immaterial or the minimum amounts have been such that they are well below the volume of goods that we have historically purchased. In addition, in the ordinary course of business, we communicate supply needs to our contract manufacturers based on orders and short-term projections, ranging from two to six months. We are committed to purchase the products produced by the contract manufacturers based on the projections provided.

Upon the termination of contracts with contract manufacturers, we obtain certain inventory control rights and are obligated to work with the contract manufacturer to sell through all product held by or manufactured by the contract manufacturer on our behalf during the termination notification period. If any inventory remains at the contract manufacturer at the termination date, we are obligated to purchase such inventory which may include raw materials, components and finished goods. The amounts for inventory purchased under termination commitments have been immaterial. 

In addition to the commitments to purchase products from contract manufacturers described above, we may also enter into commitments with other manufacturers to purchase finished goods and components to support innovation initiatives and/or supply chain initiatives. As of February 28, 2022, no such commitments were outstanding.

Share Repurchase Plan

The information required by this item is incorporated by reference to Part I—Item 1, “Notes to Condensed Consolidated Financial Statements” Note 8 — Share Repurchase Plan, included in this report.

‎

37

Dividends

On March 15, 2022, the Company’s Board of Directors declared a cash dividend of $0.78 per share payable on April 29, 2022 to shareholders of record on April 15, 2022.

Critical Accounting Policies

Our discussion and analysis of our operating results and financial condition is based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States of America.

Critical accounting policies are those that involve subjective or complex judgments, often as a result of the need to make estimates. The following areas all require the use of judgments and estimates: revenue recognition, accounting for income taxes and impairment of definite-lived intangible assets. Estimates in each of these areas are based on historical experience and various judgments and assumptions that we believe are appropriate. Actual results may differ from these estimates.

There have been no material changes in our critical accounting policies from those disclosed in Part II―Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 2 to our consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

Recently Issued Accounting Standards

Information on Recently Issued Accounting Standards that could potentially impact our consolidated financial statements and related disclosures is incorporated by reference to Part I—Item 1, “Notes to Condensed Consolidated Financial Statements” Note 2 — Basis of Presentation and Summary of Significant Accounting Policies, included in this report. 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The information required by this item is incorporated by reference to Part II―Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

Item 4. Controls and Procedures

The term “disclosure controls and procedures” is defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (“Exchange Act”). The term disclosure controls and procedures means controls and other procedures of a company that are designed to ensure the information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures. The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures as of February 28, 2022, the end of the period covered by this report (the Evaluation Date), and they have concluded that, as of the Evaluation Date, such controls and procedures were effective at ensuring that required information will be disclosed on a timely basis in the Company’s reports filed under the Exchange Act. Although management believes the Company’s existing disclosure controls and procedures are adequate to enable the Company to comply with its disclosure obligations, management continues to review and update such controls and procedures. The Company has a disclosure committee, which consists of certain members of the Company’s senior management.

There were no changes in our internal control over financial reporting during the three months ended February 28, 2022 that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

‎

38

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

The information required by this item is incorporated by reference to the information set forth in Part I—Item 1, “Notes to Condensed Consolidated Financial Statements” Note 11 — Commitments and Contingencies, included in this report.

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I—Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On October 12, 2021, the Company’s Board of Directors approved a new share repurchase plan. Under the plan, which became effective on November 1, 2021, the Company is authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023. The timing and amount of repurchases are based on terms and conditions as may be acceptable to the Company’s Chief Executive Officer and Chief Financial Officer, subject to present loan covenants and in compliance with all laws and regulations applicable thereto. During the period from December 1, 2021 through February 28, 2022, the Company repurchased 78,637 shares at a total cost of $18.2 million under this $75.0 million plan.

The following table provides information with respect to all purchases made by the Company during the three months ended February 28, 2022. All purchases listed below were made in the open market at prevailing market prices. Purchase transactions between December 1, 2021 and January 11, 2022 were executed pursuant to trading plans adopted by the Company pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.

					Total Shares Purchased		Max $ Value of Shares
					as Part of Publicly		That May Yet Be
	Total # of Shares		Average Price Paid		Announced Plans		Purchased Under the
	Purchased		Per Share		& Programs		Plans & Programs
Period
December 1 - December 31		19,750	$	232.07		19,750	$	63,030,398
January 1 - January 31		26,887	$	230.41		26,887	$	56,834,925
February 1 - February 28		-	$	-		-	$	56,834,925
Total		46,637	$	-		46,637

a

‎

39

Item 6. Exhibits

HIDDEN_ROW
Exhibit No.	Description
3(a)	Certificate of Incorporation, incorporated by reference from the Registrant’s Form 10-K filed October 21, 2020, Exhibit 3(a) thereto.
3(b)	Amended and Restated Bylaws of WD-40 Company, incorporated by reference from the Registrant’s Form 8-K filed August 16, 2018, Exhibit 3.1 thereto.
10(a)	Libor Transition Agreement dated November 29, 2021 among the Company and Bank of America, N.A., incorporated by reference from the Registrant's Form 8-K filed December 1, 2021, Exhibit 10(a) thereto.
10(b)	Change of Control Severance Agreement between WD-40 Company and Phenix Q. Kiamilev dated December 13, 2021.
10(c)	Transition and Release Agreement, dated March 11, 2022, between WD-40 Company and Garry O. Ridge, incorporated by reference from the Registrant’s Form 8-K filed March 16, 2022, Exhibit 10.1 thereto.
10(d)	FY 2022 Restricted Stock Unit Award Agreement, dated March 11, 2022, between WD-40 Company and Garry O. Ridge, incorporated by reference from the Registrant’s Form 8-K filed March 16, 2022, Exhibit 10.2 thereto.
31(a)	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31(b)	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32(a)	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32(b)	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following materials from WD-40 Company’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Operations; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Shareholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) Notes to the Condensed Consolidated Financial Statements.
104	The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101.

‎

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	WD-40 COMPANY Registrant
Date: April 7, 2022	By:	/s/ GARRY O. RIDGE
		Garry O. Ridge Chief Executive Officer (Principal Executive Officer)
	By:	/s/ JAY W. REMBOLT
		Jay W. Rembolt Vice President, Finance Treasurer and Chief Financial Officer
	By:	/s/ RAE ANN PARTLO
		Rae Ann Partlo Vice President, Corporate Controller and Principal Accounting Officer

41

EX-10.B

Exhibit 10(b)

CHANGE OF CONTROL SEVERANCE AGREEMENT

THIS AGREEMENT (“Agreement”) is made on this 13th day of December, 2021 (the “Effective Date”) between WD-40 COMPANY (hereinafter the “Company”) and Phenix Kiamilev (hereinafter the “Executive”).

RECITALS:

WHEREAS, the Company has determined that the Executive is among that group of key managers whose services and participation in management may be critical in any period of transition, such as at the time of any change in control of the Company or in the face of any proposed corporate reorganization or acquisition, friendly or hostile, affecting the Company.  Accordingly, the board of directors of the Company (the “Board”) has determined that it is appropriate and in the best interests of the Company and its stockholders that provisions be made to encourage the Executive’s continued attention and undistracted dedication to the Executive’s duties in the potentially disturbing circumstances of a possible change in control of the Company, by providing the Executive with some degree of personal financial security under such circumstances.

NOW THEREFORE, the parties agree as follows:

1.Change in Control:  For purposes of this Agreement, Change in Control shall mean: 

(a) the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (i) the then-outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however, that the following acquisitions shall not constitute a Change in Control:  (A) any acquisition directly from the Company (excluding an acquisition by virtue of the exercise of a conversion privilege), (B) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company or (C) any acquisition by any corporation pursuant to a reorganization, merger or consolidation, if, following such reorganization, merger or consolidation, the conditions described in subclauses (i), (ii) and (iii) of subparagraph (c) of this sentence are satisfied; or

(b) if individuals who, as of the date hereof, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least two-thirds of the directors then constituting the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest subject to Rule 14a-11 of Regulation 14A promulgated under the Exchange Act or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or

(c) approval by the stockholders of the Company of a reorganization, merger or consolidation, unless following such reorganization, merger or consolidation (i) more than 60% of, respectively, the then-outstanding shares of common stock of the corporation resulting from such reorganization, merger or consolidation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such reorganization, merger, or consolidation in substantially the same proportions as their ownership, immediately prior to such reorganization, merger or consolidation, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be (for purposes of determining whether such percentage test is satisfied, there shall be excluded from the number of shares and voting securities of the resulting corporation owned by the Company's stockholders, but not from the total number of outstanding shares and voting securities of the resulting corporation, any shares or voting securities received by any such stockholder in respect of any consideration other than shares or voting securities of the Company); (ii) no Person (excluding the Company, any employee benefit plan (or related trust) of the Company, any qualified employee benefit plan of such corporation resulting from such reorganization, merger or consolidation and any Person beneficially owning, immediately prior to such reorganization, merger or consolidation, directly or indirectly, 20% or more of the Outstanding Company Common Stock or Outstanding Company Voting Securities, as the case may be) beneficially

owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such reorganization, merger or consolidation or the combined voting power of the then-outstanding voting securities of such corporation entitled to vote generally in the election of directors; and (iii) at least a majority of the members of the board of directors of the corporation resulting from such reorganization, merger or consolidation were members of the Incumbent Board at the time of the execution of the initial agreement providing for such reorganization, merger or consolidation; or

(d)(i) approval by the stockholders of the Company of a complete liquidation or dissolution of the Company or (ii) the first to occur of (A) the sale or other disposition (in one transaction or a series of related transactions) of all or substantially all of the assets of the Company, or (B) the approval by the stockholders of the Company of any such sale or disposition, other than, in each case, any such sale or disposition to a corporation, with respect to which immediately thereafter, (1) more than 60% of, respectively, the then-outstanding shares of common stock of such corporation and the combined voting power of the then-outstanding voting securities of such corporation entitled to vote generally in the election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such sale or other disposition in substantially the same proportion as their ownership, immediately prior to such sale or other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be (for purposes of determining whether such percentage test is satisfied, there shall be excluded from the number of shares and voting securities of the transferee corporation owned by the Company’s stockholders, but not from the total number of outstanding shares and voting securities of the transferee corporation, any shares or voting securities received by any such stockholder in respect of any consideration other than shares or voting securities of the Company); (2) no Person (excluding the Company, any employee benefit plan (or related trust) of the Company, any qualified employee benefit plan of such transferee corporation and any Person beneficially owning, immediately prior to such sale or other disposition, directly or indirectly, 20% or more of the Outstanding Company Common Stock or Outstanding Company Voting Securities, as the case may be) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of such transferee corporation and the combined voting power of the then-outstanding voting securities of such transferee corporation entitled to vote generally in the election of directors; and (3) at least a majority of the members of the board of directors of such transferee corporation were members of the Incumbent Board at the time of the execution of the initial agreement or action of the board providing for such sale or other disposition of assets of the Company.

2.Termination Following a Change in Control: 

(a)The Executive shall be entitled to the compensation provided for in Paragraph 3 if all of the following conditions are satisfied: 

(i)  there is a Change in Control of the Company while the Executive is still an employee of the Company;

(ii)  the Executive’s employment with the Company is terminated within two years after the Change in Control; and

(iii)  the Executive's termination of employment is not a result of (A) the Executive's death; (B) the Executive’s Disability (as defined in subparagraph 2(b) below); (C) the Executive’s Retirement (as defined in subparagraph 2(c) below); (D) the Executive's termination by the Company for Cause (as defined in subparagraph 2(d) below); or (E) the Executive’s decision to terminate employment other than for Good Reason (as defined in subparagraph 2(e) below).  Notwithstanding the foregoing, if a Change of Control occurs and if the Executive's employment with the Company is terminated prior to the date on which the Change of Control occurs, and if it is reasonably demonstrated by the Executive that such termination of employment (i) was at the request of a third party who has taken steps reasonably calculated to effect a Change of Control or (ii) otherwise arose in connection with or in anticipation of a Change of Control, then the Executive shall be entitled to the compensation provided for in Paragraph 3.

(b)  If, as a result of the Executive’s incapacity due to physical or mental illness, the Executive shall have been unable, with or without a reasonable accommodation, to perform the Executive’s duties with the Company on a full time basis for six months and if, within 30 days after a Notice of Termination (as defined in subparagraph 2(f)) is thereafter given by the Company, the Executive shall not have returned to the full time performance of the Executive's duties, the Company may terminate the Executive's employment for “Disability”.

(c)  The term “Retirement” as used in this Agreement shall mean termination by the Company or the Executive of the Executive’s employment under circumstances whereby the Executive is otherwise entitled to receive benefits payable under the presently existing Supplemental Retirement Benefit Plan entered into between the Company and the Executive or such other nonqualified retirement benefit plan providing substantially similar benefits.

(d)  The Company may terminate the Executive's employment for Cause before or after a Change in Control.  For purposes of this Agreement only, “Cause” shall mean:  (i) the Executive’s commission of acts subject to prosecution as a felony involving moral turpitude; (ii) the Executive’s material breach of fiduciary duty as an executive officer of the Company which has resulted, or is likely to result, in material economic damage to the Company; or (iii) the Executive’s willful gross misconduct or willful gross neglect of duties (other than any such neglect resulting from the Executive's incapacity due to physical or mental illness or any such neglect after the issuance of a Notice of Termination by the Executive for Good Reason, as such terms are defined in subparagraphs (e) and (f) below and as they may apply under this Paragraph 2); provided that no act or failure to act by the Executive will constitute “Cause” under clause (ii) if the Executive believed in good faith that such act or failure to act was in the best interest of the Company.

Any termination of the Executive’s employment by the Company for Cause shall be authorized by a vote of at least a majority of the independent members of the Board (as they may be determined by the Board from time to time) within 12 months of a majority of such independent members of the Board having actual knowledge of the event or circumstances providing a basis for such termination.  In the case of clauses (i) and (ii) of the second sentence of this subparagraph (d), the Executive shall be given notice by the Board specifying in detail the particular act or failure to act on which the Board is relying in proposing to terminate the Executive for Cause and offering the Executive an opportunity, on a date at least 14 days after receipt of such notice, to have a hearing, with counsel, before a majority of the independent members of the Board, including each of the members of the Board who authorized the termination for Cause.  The Executive shall not be terminated for Cause if, within 30 days after the date of the Executive’s hearing before the Board (or if the Executive waives a hearing, within 30 days after receiving notice of the proposed termination), the Executive has corrected the particular act or failure to act specified in the notice given under clause (ii) of the second sentence of this subparagraph (d), and by so correcting such act or failure to act the Executive has reduced the economic damage the act or failure to act has allegedly caused the Company to a level which is no longer material or has eliminated the probability that such act or failure to act is likely to result in material economic damage to the Company.  No termination for Cause shall take effect until the expiration of the correction period described in the preceding sentence and the determination by a majority of the independent members of the Board that the Executive has failed to correct the act or failure to act in accordance with the terms of the preceding sentence.  Other than as specified herein, the decision of a majority of the independent members of the Board of Directors with respect to any determination of the grounds for termination of the Executive’s employment for Cause shall be binding absent evidence of bad faith or manifest injustice.

(e)  The Executive may terminate the Executive’s employment for Good Reason at any time following a Change in Control.  For purposes of this Agreement, “Good Reason” shall mean, after any Change in Control and without the Executive’s express written consent, any of the following:

(i)  a significant diminution in the Executive's duties and responsibilities, or the assignment to the Executive by the Company of duties inconsistent with the Executive's position, duties, responsibilities or status with the Company immediately prior to a Change in Control of the Company, or any removal of the Executive from or any failure to re-elect the Executive to any of such positions, except in connection with the termination of employment for Disability, Retirement or Cause or as a result of the Executive’s death or by the Executive other than for Good Reason;

(ii)  a reduction by the Company in the Executive’s annual rate of base salary as in effect immediately prior to a Change of Control or the Company’s failure to increase (within 12 months of the Executive’s last adjustment in annual rate of base salary) the Executive's annual rate of base salary after a Change in Control of the Company in an amount which at least equals, on a percentage basis, the average percentage increase in the annual rate of base salary most recently or then currently being effected for all other executive officers of the Company;

(iii)  (A) any failure by the Company to continue in effect any benefit plan or arrangement (including, without limitation, medical, dental, and other established benefit plans (“Welfare Benefit Plans”), group life insurance and retirement plans) in which the Executive is participating at the time of a Change in Control of the Company (all hereinafter referred to as “Benefit Plans”) unless the Executive receives benefits through another plan or arrangement providing the Executive with benefits, when considered in the aggregate, that are no less favorable than the benefits under all Benefit Plans available to the Executive at the time of a Change in Control, or (B) the taking of any action by the Company which would adversely affect the Executive’s participation in or materially reduce the Executive’s benefits under the Benefit Plans or otherwise deprive the Executive of any material fringe benefit or perquisite of office enjoyed by the Executive at the time of a Change in Control of the Company considered in the aggregate with all benefits so provided to the Executive;

(iv)  (A) any failure by the Company to continue in effect any incentive plan or arrangement (including, without limitation, the Company’s incentive bonus and contingent bonus arrangements and credits and the right to receive performance awards and similar long and short-term incentive compensation benefits) in which the

Executive is participating at the time of a Change in Control of the Company (hereinafter referred to as “Incentive Plans”), (B) the taking of any action by the Company which would adversely affect the Executive’s participation in any such Incentive Plan or reduce the Executive’s benefits under any such Incentive Plan, unless in the case of either subclause (A) or (B) above, there is substituted a comparable plan or program that is economically equivalent, in terms of the benefit offered to the Executive, to the Incentive Plan being altered, reduced, affected or ended, or (C) any failure by the Company with respect to any fiscal year to make an award to the Executive pursuant to each such Incentive Plan or such substituted comparable plan or program in accordance with its terms or otherwise in a manner consistent with awards or benefits provided to other executive officers of the Company;

(v)  (A) any failure by the Company to continue in effect any plan or arrangement to receive securities of the Company (including, without limitation, the Company's stock option plans and other equity incentive plans as authorized by the Board for the senior executive officers) in which the Executive is participating at the time of a Change in Control of the Company (hereinafter referred to as “Securities Plans”), or the taking of any action by the Company which would adversely affect the Executive's participation in or materially reduce the Executive’s benefits under any such Securities Plan or (B) any failure by the Company in any fiscal year to grant stock options, stock appreciation rights or securities awards to the Executive pursuant to such Securities Plans or otherwise in a manner consistent with awards or grants provided to other executive officers of the Company; and provided further that the material terms and conditions of such stock options, stock appreciation rights, and securities awards granted to the Executive after the Change in Control (including, but not limited to, the exercise price, vesting schedule, period and methods of exercise, expiration date, forfeiture provisions and other restrictions) are substantially similar to the material terms and conditions of the stock options, stock appreciation rights, and securities awards granted to the Executive under the Securities Plans immediately prior to the Change in Control of the Company;

(vi)  a relocation of the Company’s principal executive offices to a location more than 100 miles outside of San Diego, California, or the Executive’s relocation more than 100 miles from the location at which the Executive performed the Executive's duties prior to a Change in Control of the Company, except for required travel by the Executive on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations at the time of a Change in Control of the Company;

(vii)  any failure by the Company to provide the Executive with the number of annual paid vacation days to which the Executive is entitled for the year in which a Change in Control of the Company occurs;

(viii)  any material breach by the Company of any provision of this Agreement;

(ix)  any failure by the Company to obtain the assumption of this Agreement by any successor or assign of the Company;

(x)  the Company or its successor no longer is required to have its common stock registered pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934, as amended; or

(xi)  any purported termination of the Executive’s employment by the Company pursuant to subparagraphs 2(b), 2(c) or 2(d) which is not effected pursuant to a Notice of Termination satisfying the requirements of subparagraph 2(f) below (and, if applicable, subparagraph 2(d) above), and for purposes of this Agreement, no such purported termination shall be effective.

For purposes of this subparagraph (e), an isolated, immaterial, and inadvertent action not taken in bad faith by the Company in violation of clauses (i) - (v), (vii) or (xi) of this subparagraph that is remedied by the Company promptly after receipt of notice thereof given by the Executive shall not be considered Good Reason for the Executive’s termination of employment with the Company.  In the event the Executive terminates the Executive’s employment for Good Reason hereunder, then notwithstanding that the Executive may also be considered retired for purposes of Benefit Plans (other than the Supplemental Retirement Benefit Plan or other non-qualified plan providing similar benefits), Incentive Plans or Securities Plans, the Executive shall be deemed to have terminated employment for Good Reason for purposes of this Agreement.

(f)  Any termination of the Executive’s employment by the Company pursuant to subparagraphs 2(b), 2(c) or 2(d), or by the Executive pursuant to subparagraph 2(e) above, shall be communicated by a Notice of Termination to the other party hereof.  For purposes of this Agreement, a “Notice of Termination” shall mean a written notice which shall indicate those specific termination provisions in this Agreement relied upon and which sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated.  For purposes of this Agreement, no such purported termination by the Company shall be effective without such Notice of Termination.

(g)  “Date of Termination” shall mean (i) if the Executive’s employment is terminated by the Company for Disability, 30 days after Notice of Termination is given to the Executive (provided that the Executive shall not have returned to the performance of the Executive’s duties on a full time basis during such 30 day period),

(ii) if the Executive’s employment is terminated by the Executive for Good Reason, the date specified in the Notice of Termination, and (iii) if the Executive’s employment is terminated by the Company for any other reason, the date on which a Notice of Termination is given; provided, however, that if within 30 days after any Notice of Termination is given to the Executive by the Company, the Executive notifies the Company that a dispute exists concerning the termination, the Date of Termination shall be a date no earlier than the date on which the Notice of Termination is given, but otherwise, if the termination is to be effective, as of the date so determined, whether by mutual written agreement of the parties or upon final judgment, order or decree of a court of competent jurisdiction.

3.Severance Compensation Upon Termination of Employment Following a Change in Control: 

(a)  If, pursuant to subparagraph 2(a), the Executive is entitled to the compensation provided for in this Paragraph 3, then, subject to the provisions of Paragraph 7 below, the Company shall pay to the Executive in a lump sum cash payment, the following:

(i)  the Change in Control Severance Amount as defined in subparagraph 3(b) below within five days following, but not earlier than, the sixth month anniversary of the Date of Termination; plus

(ii)  the Executive’s earned but unpaid base annual salary through the period ending on the Date of Termination within the time required by law for the payment of wages upon termination of employment; plus

(iii)  interest, if any, on the amounts payable pursuant to clauses (i) and (ii) above calculated from the Date of Termination until paid (including interest calculated for the six month period from the Date of Termination to the date of payment pursuant to clause (i) or from the Date of Termination to the date of payment pursuant to clause (ii) if not paid when due) at a rate equal to the prime rate as published in the Wall Street Journal on the Date of Termination plus three percentage points, compounded annually. 

(b)  “Change in Control Severance Amount” shall mean an amount equal to the sum of (i) two times the greater of (A) the Executive’s base annual salary in effect as of the Date of Termination or (B) the average of the Executive’s base annual salary paid for the five fiscal years ending prior to the Date of Termination, plus (ii) two times the greater of (A) the annual cash bonus awarded by the Board to the Executive with respect to the Company's most recent fiscal year ending prior to the Date of Termination or (B) the average of the annual cash bonus amounts awarded by the Board to the Executive with respect to the Company's most recent five fiscal years ending prior to the Date of Termination.

(c)If, pursuant to subparagraph 2(a), the Executive is entitled to the compensation provided in this Paragraph 3, then the Executive will be entitled to continued participation in all Welfare Benefit Plans (as defined in subparagraph 2(e)(iii) above) in which the Executive was participating on the Date of Termination, such continued participation to be at Company cost and otherwise on the same basis as Company employees generally, until the earlier of (i) the date, or dates, the Executive receives equivalent coverage and benefits under the plans and programs of a subsequent employer (such coverages and benefits to be determined on a coverage-by-coverage or benefit-by-benefit basis) or (ii) two years from the Date of Termination; provided (A) if the Executive is precluded from continuing participation in any Welfare Benefit Plan as provided in this sentence, the Executive shall be paid, in a lump sum cash payment, within 30 days following the date it is determined the Executive is unable to participate in any Welfare Benefit Plan, the after-tax economic equivalent of the benefits provided under the plan or program in which the Executive is unable to participate for the period specified in this sentence, and (B) the economic equivalent of any benefit foregone shall be deemed to be the lowest cost that would be incurred by the Executive in obtaining such benefit (including family or dependent coverage, if applicable) on an individual basis.  The Executive shall be eligible for group health plan continuation coverage under and in accordance with the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, when the Executive ceases to be eligible for continued participation in the Company's group health plan under this subparagraph (c).

4.Company Right to Terminate Employment With or Without Cause; No Obligation of Executive to Mitigate Damages; No Effect On Other Contractual Rights:

(a)Notwithstanding anything to the contrary herein, the Executive shall serve the Company at the pleasure of the Board and the Board may terminate the Executive’s employment at any time, with our without Cause subject to the Executive’s right to payment of the severance compensation provided for herein, if applicable.  The Executive hereby acknowledges that this agreement does not guarantee continued employment with the Company for any period of time and upon termination of the Executive’s employment, the Executive shall have no claim for compensation or other benefits pursuant to this agreement except as specifically set forth herein following a Change of Control.

(b)  The Executive shall not be required to mitigate damages or the amount of any payment provided for under this Agreement by seeking other employment or otherwise, nor shall the amount of any payment

provided for under this Agreement be reduced by any compensation earned by the Executive as the result of employment by another employer after the Date of Termination or otherwise.

(c)  The provisions of this Agreement, and any payment provided for hereunder, shall not reduce any amounts otherwise payable, or in any way diminish the Executive’s existing rights, or rights which would accrue solely as a result of the passage of time, under any Benefit Plan, Incentive Plan or Securities Plan, or other contract, plan or agreement with or of the Company.

5.Options, Securities Awards, And Incentive Awards:

(a)  In the event of a Change in Control of the Company, then notwithstanding the terms and conditions of any Securities Plan or other plan, agreement or arrangement, (i) if any Securities Plan will not be continued as to the securities of the Company or as to substantially equivalent publicly traded securities of the Company or any successor entity, or (ii) if the Executive’s employment is terminated and the Executive is entitled to the compensation provided for in Paragraph 3, then the Company agrees to accelerate, vest, and make immediately exercisable in full all unexercisable installments of all options to acquire securities of the Company, to vest all unvested awards of securities of the Company and to waive any resale or other restrictions or rights of repurchase applicable to securities underlying such options or applicable to awards of securities of the Company in each case, which are held by the Executive on the date of such Change in Control, including without limitation any options or securities obtained by the Executive pursuant to any Securities Plan or securities obtained by the Executive pursuant to any discontinued Incentive Plan (as defined in subparagraph 2(e)) to the extent that the Executive may not otherwise be able to realize the expected benefits thereof upon continued employment by the Company or a publicly traded successor entity.

(b)  If the provisions of subparagraph (a) of this Paragraph 5 are applicable with respect to any Securities Plan within six (6) months following a Change in Control, any options or securities obtained by the Executive pursuant to the discontinued Securities Plan or securities obtained by the Executive pursuant to any Incentive Plan as described in subparagraph (a) shall have a limited right of surrender allowing the Executive to surrender such options or securities within the 30 day period following the date on which the provisions of subparagraph (a) first become applicable and to receive a cash payment in exchange for the surrender of such options or securities.  The amount of such payment shall be equal to the sum of (i) the product of the number of securities obtained by the Executive pursuant to such Securities Plan or Incentive Plan multiplied by the greater of (x) the fair market value of the securities of the Company on the date prior to the Change in Control or (y) the per share price paid to shareholders in connection with such Change in Control (alternatively, the “Securities Price”) and (ii) the product of (a) the number of securities covered by options multiplied by (b) the positive amount, if any, equal to the Securities Price minus the exercise price.  Notwithstanding the foregoing, if any such payment would result in liability under Section 16 of the Exchange Act, the right of surrender shall commence upon the earliest date it can be exercised by the Executive without liability and continue for thirty days thereafter.

6.Termination:  This Agreement shall continue in effect for a period of two (2) years and shall automatically renew for successive two (2) year periods from the earlier of (a) the next scheduled termination date, unless the Board provides the Executive with a notice of non-renewal at least 6 months before the next scheduled termination date, or (b) the effective date of a Change of Control.

7.Adjustment Related to Application of Excise Tax:  If the Executive is entitled to receive the compensation provided for in Paragraph 3 and any payment received or to be received by the Executive is or will be subject to the tax (the “Excise Tax”) imposed by Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), the adjustment set forth in subparagraph (a) shall be made to the payments provided for in Paragraph 3 above.

(a)If the present value of all benefits and payments to the Executive included in the determination of “parachute payments” pursuant to Section 280G(b)(2) of the Code received by or to be received by the Executive (the “Parachute Payments”) is equal to or exceeds 3 times the “base amount” with respect to the Executive as determined pursuant to Section 280G(b)(3) of the Code (the “Base Amount”), then the amount payable to the Executive pursuant to Paragraph 3 above shall be reduced so that the present value of the Parachute Payments is equal to 3 times the  Base Amount minus the sum of One Hundred Dollars ($100.00.)

(b)It is the intention of the parties to this Agreement that the compensation payable to the Executive pursuant to this Agreement contingent upon a Change of Control of the Company will not result in any “excess parachute payment” to the Executive as determined under Section 280G(b) of the Code or application of the Excise Tax to any such excess parachute payment. The provisions of this Paragraph 7 shall be applied so as to carry out the parties’ intention with respect to such tax treatment.  Each party agrees to take such action as may be necessary or appropriate to carry out the provisions of this Paragraph 7 and to cooperate with the other as to all required determinations, including the payment or return of any payment determined to be due to the Executive or to the Company, respectively.  The Company shall pay all costs of accounting to assure compliance with the intent of this Paragraph 7.

8.Successors:  The Company will require any successor or assign (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company, by agreement in form and substance satisfactory to the Executive, expressly, absolutely and unconditionally to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession or assignment had taken place.  Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the Executive to terminate the Executive’s employment for Good Reason and receive the compensation provided for in Paragraph 3 above.  As used in this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor or assign to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Paragraph 8 or which otherwise becomes bound by all the terms and provisions of this Agreement by operation of law.

9.Survivorship:  The respective rights and obligations of the parties hereunder shall survive any termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations and to the extent that any performance is required following termination of this Agreement.

10.Notices:  Any notice, request, demand or other communication required or permitted hereunder shall be deemed to be properly given when personally served in writing, when deposited in the United States mail, postage prepaid, or when communicated to a public telegraph company for transmittal, addressed to the Company at its head office location or the Executive at the Executive’s last known address.  Either party may change its address by written notice in accordance with this paragraph.

11.Benefit of Agreement:  This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal and legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.  If the Executive should die while any amounts are still payable to the Executive hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive's devisee, legatee or other designee or, if there be no such designee, to the Executive’s estate.

12.Applicable Law:  Except to the extent governed by the laws of the United States, this Agreement is to be governed by and construed under the laws of the State of California.

13.Captions and Paragraph Headings:  Captions and paragraph headings used herein are for convenience only and are not a part of this Agreement and shall not be used in the interpretation of this Agreement.

14.Invalid Provisions:  Should any provision of this Agreement for any reason be declared invalid, void or unenforceable by a court of competent jurisdiction, the validity and binding effect of any remaining portion shall not be affected, and the remaining portions of this Agreement shall remain in full force and effect as if this Agreement had been executed with said provision eliminated.

15.Entire Agreement:  This Agreement contains the entire agreement of the parties.  It supersedes any and all other agreements, either oral or in writing, between the parties hereto with respect to the matters covered herein.  Each party to this Agreement acknowledges that no representations, inducements, promises, or agreements, oral or otherwise, have been made by any party, or anyone acting on behalf of any party, which are not embodied herein, and that no other agreement, statement, or promise relating to the matters covered herein and not contained in this Agreement shall be valid or binding.  This Agreement may not be modified or amended by oral agreement, but only by any agreement in writing signed by the Company and the Executive.

16.Attorney’s Fees:  If any action, including arbitration, is brought to enforce this Agreement or to determine the relative rights and obligations of either of the parties and a ruling is obtained in favor of either party, regardless of which party institutes the action, the prevailing party will be entitled to reasonable attorney’s fees.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

“COMPANY”		“EXECUTIVE”
WD-40 COMPANY
By	/s/ GARRY O. RIDGE	/s/PHENIX Q. KIAMILEV
	GARRY O. RIDGE, CEO	PHENIX Q. KIAMILEV
By	/s/ RICHARD T. CLAMPITT
	RICHARD T. CLAMPITT, Secretary

EX-31.A

Exhibit 31(a)

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Garry O. Ridge, certify that:

1. I have reviewed this report on Form 10-Q of WD-40 Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: April 7, 2022

/s/ GARRY O. RIDGE

Garry O. Ridge

Chief Executive Officer

EX-31.B

Exhibit 31(b)

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jay W. Rembolt, certify that:

1. I have reviewed this report on Form 10-Q of WD-40 Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: April 7, 2022

/s/ JAY W. REMBOLT

Jay W. Rembolt

Vice President, Finance, Treasurer and Chief Financial Officer

EX-32.A

Exhibit 32(a)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Garry O. Ridge, Chief Executive Officer of WD-40 Company (the “Company”), have reviewed the Quarterly Report on Form 10-Q of the Company for the quarter ended February 28, 2022 (the “Report”). For purposes of Section 1350 of Title 18, United States Code, I certify that to the best of my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 7, 2022

/s/ GARRY O. RIDGE

Garry O. Ridge

Chief Executive Officer

EX-32.B

Exhibit 32(b)

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Jay W. Rembolt, Chief Financial Officer of WD-40 Company (the “Company”), have reviewed the Quarterly Report on Form 10-Q of the Company for the quarter endedFebruary 28, 2022 (the “Report”). For purposes of Section 1350 of Title 18, United States Code, I certify that to the best of my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 7, 2022

/s/ JAY W. REMBOLT

Jay W. Rembolt

Vice President, Finance, Treasurer and Chief Financial Officer

XML

Document and Entity Information - shares	6 Months Ended
	Feb. 28, 2022	Apr. 04, 2022
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Amendment Flag	false
Document Period End Date	Feb. 28, 2022
Entity File Number	000-06936
Entity Registrant Name	WD-40 COMPANY
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	95-1797918
Entity Address, Address Line One	9715 Businesspark Avenue
Entity Address, City or Town	San Diego
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92131
City Area Code	619
Local Phone Number	275-1400
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	WDFC
Security Exchange Name	NASDAQ
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000105132
Current Fiscal Year End Date	--08-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		13,660,980

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Current assets:
Cash and cash equivalents	$ 43,322	$ 85,961
Trade and other accounts receivable, less allowance for doubtful accounts of $366 and $463 at February 28, 2022 and August 31, 2021, respectively	103,582	89,558
Inventories	75,537	55,752
Other current assets	12,158	9,948
Total current assets	234,599	241,219
Property and equipment, net	69,334	70,145
Goodwill	95,754	95,869
Other intangible assets, net	6,478	7,244
Operating lease right-of-use assets	8,115	8,824
Deferred tax assets, net	853	858
Other assets	8,013	6,044
Total assets	423,146	430,203
Current liabilities:
Accounts payable	39,655	33,499
Accrued liabilities	28,130	25,658
Accrued payroll and related expenses	13,133	25,662
Short-term borrowings	2,038	800
Income taxes payable	433	317
Total current liabilities	83,389	85,936
Long-term borrowings	112,809	114,940
Deferred tax liabilities, net	10,717	10,401
Long-term operating lease liabilities	6,356	7,062
Other long-term liabilities	11,025	11,482
Total liabilities	224,296	229,821
Commitments and Contingencies (Note 11)
Shareholders' equity:
Common stock ― authorized 36,000,000 shares, $0.001 par value; 19,887,516 and 19,856,865 shares issued at February 28, 2022 and August 31, 2021, respectively; and 13,660,980 and 13,708,966 shares outstanding at February 28, 2022 and August 31, 2021, respectively	20	20
Additional paid-in capital	164,192	163,737
Retained earnings	448,179	430,735
Accumulated other comprehensive loss	(27,296)	(26,030)
Common stock held in treasury, at cost ― 6,226,536 and 6,147,899 shares at February 28, 2022 and August 31, 2021, respectively	(386,245)	(368,080)
Total shareholders' equity	198,850	200,382
Total liabilities and shareholders' equity	$ 423,146	$ 430,203

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Condensed Consolidated Balance Sheets [Abstract]
Trade and other accounts receivable, less allowance for doubtful accounts	$ 366	$ 463
Common stock, shares authorized	36,000,000	36,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	19,887,516	19,856,865
Common stock, shares outstanding	13,660,980	13,708,966
Treasury stock, shares	6,226,536	6,147,899

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Condensed Consolidated Statements Of Operations [Abstract]
Net sales	$ 129,986	$ 111,905	$ 264,732	$ 236,464
Cost of products sold	64,468	49,898	130,744	104,211
Gross profit	65,518	62,007	133,988	132,253
Operating expenses:
Selling, general and administrative	34,819	35,478	73,242	71,455
Advertising and sales promotion	5,596	5,512	11,220	11,031
Amortization of definite-lived intangible assets	360	362	723	720
Total operating expenses	40,775	41,352	85,185	83,206
Income from operations	24,743	20,655	48,803	49,047
Other income (expense):
Interest income	21	19	46	38
Interest expense	(613)	(610)	(1,233)	(1,180)
Other income (expense), net	252	151	(77)	330
Income before income taxes	24,403	20,215	47,539	48,235
Provision for income taxes	4,895	3,024	9,476	7,421
Net income	$ 19,508	$ 17,191	$ 38,063	$ 40,814
Earnings per common share:
Basic	$ 1.41	$ 1.25	$ 2.76	$ 2.97
Diluted	$ 1.41	$ 1.24	$ 2.75	$ 2.96
Shares used in per share calculations:
Basic	13,679	13,700	13,773	13,687
Diluted	13,704	13,729	13,804	13,718

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Condensed Consolidated Statements Of Comprehensive Income [Abstract]
Net income	$ 19,508	$ 17,191	$ 38,063	$ 40,814
Other comprehensive income (loss):
Foreign currency translation adjustment	627	3,234	(1,266)	3,822
Total comprehensive income	$ 20,135	$ 20,425	$ 36,797	$ 44,636

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]	Total
Beginning balance at Aug. 31, 2020	$ 20	$ 157,850	$ 398,731	$ (28,208)	$ (368,080)	$ 160,313
Beginning balance, shares at Aug. 31, 2020	19,812,685				6,147,899
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes		(3,490)				(3,490)
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes, shares	23,417
Stock-based compensation		2,665				2,665
Cash dividends			(9,199)			(9,199)
Foreign currency translation adjustment				588		588
Net income			23,623			23,623
Ending balance at Nov. 30, 2020	$ 20	157,025	413,155	(27,620)	$ (368,080)	174,500
Ending balance, shares at Nov. 30, 2020	19,836,102				6,147,899
Beginning balance at Aug. 31, 2020	$ 20	157,850	398,731	(28,208)	$ (368,080)	160,313
Beginning balance, shares at Aug. 31, 2020	19,812,685				6,147,899
Foreign currency translation adjustment						3,822
Net income						40,814
Ending balance at Feb. 28, 2021	$ 20	158,897	421,129	(24,386)	$ (368,080)	187,580
Ending balance, shares at Feb. 28, 2021	19,855,666				6,147,899
Beginning balance at Nov. 30, 2020	$ 20	157,025	413,155	(27,620)	$ (368,080)	174,500
Beginning balance, shares at Nov. 30, 2020	19,836,102				6,147,899
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes		(5)				(5)
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes, shares	19,564
Stock-based compensation		1,877				1,877
Cash dividends			(9,217)			(9,217)
Acquisition of treasury stock
Foreign currency translation adjustment				3,234		3,234
Net income			17,191			17,191
Ending balance at Feb. 28, 2021	$ 20	158,897	421,129	(24,386)	$ (368,080)	187,580
Ending balance, shares at Feb. 28, 2021	19,855,666				6,147,899
Beginning balance at Aug. 31, 2021	$ 20	163,737	430,735	(26,030)	$ (368,080)	$ 200,382
Beginning balance, shares at Aug. 31, 2021	19,856,865				6,147,899	13,708,966
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes		(4,246)				$ (4,246)
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes, shares	30,072
Stock-based compensation		2,891				2,891
Cash dividends			(9,905)			(9,905)
Acquisition of treasury stock					$ (7,386)	(7,386)
Acquisition of treasury stock, shares					32,000
Foreign currency translation adjustment				(1,893)		(1,893)
Net income			18,555			18,555
Ending balance at Nov. 30, 2021	$ 20	162,382	439,385	(27,923)	$ (375,466)	198,398
Ending balance, shares at Nov. 30, 2021	19,886,937				6,179,899
Beginning balance at Aug. 31, 2021	$ 20	163,737	430,735	(26,030)	$ (368,080)	$ 200,382
Beginning balance, shares at Aug. 31, 2021	19,856,865				6,147,899	13,708,966
Foreign currency translation adjustment						$ (1,266)
Net income						38,063
Ending balance at Feb. 28, 2022	$ 20	164,192	448,179	(27,296)	$ (386,245)	$ 198,850
Ending balance, shares at Feb. 28, 2022	19,887,516				6,226,536	13,660,980
Beginning balance at Nov. 30, 2021	$ 20	162,382	439,385	(27,923)	$ (375,466)	$ 198,398
Beginning balance, shares at Nov. 30, 2021	19,886,937				6,179,899
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes		(75)				(75)
Issuance of common stock under share-based compensation plan, net of shares withheld for taxes, shares	579
Stock-based compensation		1,885				1,885
Cash dividends			(10,714)			(10,714)
Acquisition of treasury stock					$ (10,779)	(10,779)
Acquisition of treasury stock, shares					46,637
Foreign currency translation adjustment				627		627
Net income			19,508			19,508
Ending balance at Feb. 28, 2022	$ 20	$ 164,192	$ 448,179	$ (27,296)	$ (386,245)	$ 198,850
Ending balance, shares at Feb. 28, 2022	19,887,516				6,226,536	13,660,980

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Feb. 28, 2022	Nov. 30, 2021	Feb. 28, 2021	Nov. 30, 2020
Condensed Consolidated Statements Of Shareholders' Equity [Abstract]
Cash dividends, per share	$ 0.78	$ 0.72	$ 0.67	$ 0.67

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended				4 Months Ended	6 Months Ended		12 Months Ended
	Feb. 28, 2022	Nov. 30, 2021	Feb. 28, 2021	Nov. 30, 2020	Feb. 28, 2022	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021
Operating activities:
Net income	$ 19,508	$ 18,555	$ 17,191	$ 23,623		$ 38,063	$ 40,814
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,095		1,757			4,082	3,458
Net gains on sales and disposals of property and equipment						(123)	(104)
Deferred income taxes						367	152
Stock-based compensation						4,776	4,542
Unrealized foreign currency exchange (gains) losses						(110)	139
Provision for bad debts						(55)	175
Changes in assets and liabilities:
Trade and other accounts receivable						(15,178)	(10,111)
Inventories						(20,369)	(2,104)
Other assets						(4,328)	(4,386)
Operating lease assets and liabilities, net						1	9
Accounts payable and accrued liabilities						9,624	7,398
Accrued payroll and related expenses						(12,356)	1,584
Other long-term liabilities and income taxes payable						(311)	944
Net cash provided by operating activities						4,083	42,510
Investing activities:
Purchases of property and equipment						(3,860)	(7,605)
Proceeds from sales of property and equipment						289	239
Net cash used in investing activities						(3,571)	(7,366)
Financing activities:
Treasury stock purchases					$ (18,200)	(18,165)
Dividends paid						(20,619)	(18,416)
Proceeds from issuance of long-term senior notes							52,000
Repayments of long-term senior notes						(400)	(400)
Net proceeds (repayments) of revolving credit facility						1,238	(50,000)
Shares withheld to cover taxes upon conversions of equity awards						(4,321)	(3,495)
Net cash used in financing activities						(42,267)	(20,311)
Effect of exchange rate changes on cash and cash equivalents						(884)	1,086
Net (decrease) increase in cash and cash equivalents						(42,639)	15,919
Cash and cash equivalents at beginning of period		$ 85,961		$ 56,462		85,961	56,462	$ 56,462
Cash and cash equivalents at end of period	$ 43,322		$ 72,381		$ 43,322	43,322	72,381	$ 85,961
Supplemental disclosure of noncash investing activities:
Accrued capital expenditures						$ 798	$ 1,638

XML

The Company

6 Months Ended

Feb. 28, 2022

The Company [Abstract]

The Company

Note 1. The Company

WD-40 Company (the “Company”), based in San Diego, California, is a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories and homes around the world. The Company owns a wide range of well-known brands that include maintenance products and homecare and cleaning products: WD-40® Multi-Use Product, WD-40 Specialist®, 3-IN-ONE®, GT85®, 2000 Flushes®, no vac®, 1001®, Spot Shot®, Lava®, Solvol®, X-14®,and Carpet Fresh®.

The Company’s products are sold in various locations around the world. Maintenance products are sold worldwide in markets throughout North, Central and South America, Asia, Australia, Europe, the Middle East and Africa. Homecare and cleaning products are sold primarily in North America, the United Kingdom (“U.K.”) and Australia. The Company’s products are sold primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial distributors and suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike dealers.

XML

Basis Of Presentation And Summary Of Significant Accounting Policies	6 Months Ended
	Feb. 28, 2022
Basis Of Presentation And Summary Of Significant Accounting Policies [Abstract]
Basis Of Presentation And Summary Of Significant Accounting Policies	Note 2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Consolidation The condensed consolidated financial statements included herein have been prepared by the Company, without audit, according to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The August 31, 2021 year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP. In the opinion of management, the unaudited financial information for the interim periods shown reflects all adjustments necessary for a fair statement thereof and such adjustments are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. COVID-19 Considerations The COVID-19 pandemic has adversely impacted global economic conditions and has contributed to significant volatility in financial markets beginning in early calendar year 2020, as described in the “Impact of COVID-19 on Our Business” portion of the section titled “Significant Developments” included in Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Although the Company’s estimates consider current conditions, the inputs into certain of the Company’s significant and critical accounting estimates include judgments and assumptions about the economic implications of the COVID-19 pandemic and how management expects them to change in the future, as appropriate. It is reasonably possible that actual results experienced may differ materially from the Company’s estimates in future periods, which could materially affect our results of operations and financial condition. Foreign Currency Forward Contracts In the normal course of business, the Company employs established policies and procedures to manage its exposure to fluctuations in foreign currency exchange rates. The Company utilizes foreign currency forward contracts to limit its exposure to net asset balances held in non-functional currencies, primarily at its U.K. subsidiary. The Company regularly monitors its foreign currency exchange rate exposures to ensure the overall effectiveness of its foreign currency hedge positions. While the Company engages in foreign currency hedging activity to reduce its risk, for accounting purposes, none of its foreign currency forward contracts are designated as hedges. Foreign currency forward contracts are carried at fair value, with net realized and unrealized gains and losses recognized in other income (expense), net in the Company’s consolidated statements of operations. Cash flows from settlements of foreign currency forward contracts are included in operating activities in the consolidated statements of cash flows. Foreign currency forward contracts in an asset position at the end of the reporting period are included in other current assets, while foreign currency forward contracts in a liability position at the end of the reporting period are included in accrued liabilities in the Company’s consolidated balance sheets. At February 28, 2022, the Company had a notional amount of $4.5 million outstanding in foreign currency forward contracts, which matured on March 30, 2022. Unrealized net gains and losses related to foreign currency forward contracts were not significant at February 28, 2022 and August 31, 2021. Realized net gains and losses related to foreign currency forward contracts were not significant for both the three and six months ended February 28, 2022 and 2021. Both unrealized and realized net gains and losses are recorded in other income (expense), net on the Company’s condensed consolidated statements of operations. Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial assets and liabilities measured at fair value into a hierarchy that categorizes fair value measurements into the following three levels based on the types of inputs used in measuring their fair value:  Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities; Level 2: Observable market-based inputs or observable inputs that are corroborated by market data; and Level 3: Unobservable inputs reflecting the Company’s own assumptions. Under fair value accounting, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. As of February 28, 2022, the Company had no assets or liabilities that are measured at fair value in the financial statements on a recurring basis, with the exception of the foreign currency forward contracts, which are classified as Level 2 within the fair value hierarchy. The carrying values of cash equivalents and short-term borrowings are recorded at cost, which approximates their fair values, primarily due to their short-term nature. In addition, the carrying value of borrowings held under the Company’s revolving credit facility approximates fair value, based on Level 2 inputs, due to the variable nature of underlying interest rates, which generally reflect market conditions. The Company’s fixed rate long-term borrowings consist of senior notes and are recorded at carrying value. The Company estimates that the fair value of its senior notes, based on Level 2 inputs, was approximately $64.8 million as of February 28, 2022, which was determined based on a discounted cash flow analysis using current market interest rates for instruments with similar terms, compared to their carrying value of $68.8 million. During the six months ended February 28, 2022, the Company did not record any significant nonrecurring fair value measurements for assets or liabilities in periods subsequent to their initial recognition. ‎ Internal-Use Software and Cloud Computing Arrangements The Company capitalizes costs related to computer software obtained or developed for internal use. Software obtained for internal use has generally been enterprise-level business and finance software that the Company customizes to meet its specific operational needs. Costs incurred in the application development phase are capitalized as property and equipment in the Company’s consolidated balance sheets and are depreciated using the straight-line method over their estimated useful lives. The Company also enters into certain cloud-based software hosting arrangements. In evaluating whether cloud computing arrangements include an embedded internal-use software license, management considers whether the Company has the contractual right to take possession of the software during the hosting period without significant penalty and whether it is feasible to either i) run the software on the Company’s hardware, or ii) contract with another party unrelated to the vendor to host the software. If management determines a cloud computing arrangement includes an embedded software license, the Company accounts for the software license element of the arrangement consistent with the acquisition of other internal-use software licenses. If a cloud computing arrangement does not include a software license, the Company accounts for the arrangement as a service contract. For such cloud computing service contracts, the Company capitalizes certain implementation costs such as the configuration, coding and customization of the software. Capitalizable cloud computing arrangement costs are generally consistent with those incurred during the application development stage for internal-use software, however, these costs are capitalized as “other assets” in the Company’s consolidated balance sheets. The Company amortizes these capitalized cloud computing implementation costs into selling, general and administrative expenses using the straight-line method over the fixed, non-cancellable term of the associated hosting arrangement, plus any reasonably certain renewal periods. The useful lives of the Company’s internal-use software and capitalized cloud computing implementation costs are generally three to five years. However, the useful lives of major information system installations such as implementations of enterprise resource planning (“ERP”) systems are determined on an individual basis and may exceed five years depending on the estimated period of use. The Company applies the same impairment model to both internal-use software and capitalized cloud computing implementation costs. Recently Adopted Accounting Standards In December 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes” under ASC 740, which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amended existing guidance to improve consistent application. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The Company adopted this new guidance on September 1, 2021, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.

XML

Inventories

6 Months Ended

Feb. 28, 2022

Inventories [Abstract]

Inventories

Note 3. Inventories

Inventories are stated at the lower of cost or net realizable value and cost is determined based on a first-in, first-out method or, for a portion of raw materials inventory, the average cost method. Inventories consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Product held at third-party contract manufacturers	$	7,218	$	9,036
Raw materials and components		12,526		8,981
Work-in-process		1,379		802
Finished goods		54,414		36,933
Total	$	75,537	$	55,752

XML

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs

6 Months Ended

Feb. 28, 2022

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs [Abstract]

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs

Note 4. Property and Equipment and Capitalized Cloud-Based Software Implementation Costs

Property and equipment, net, consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Machinery, equipment and vehicles	$	36,004	$	22,504
Buildings and improvements		29,655		29,697
Computer and office equipment		6,094		5,742
Internal-use software		10,785		10,559
Furniture and fixtures		2,809		2,794
Capital in progress		18,236		31,016
Land		4,379		4,406
Subtotal		107,962		106,718
Less: accumulated depreciation and amortization		(38,628)		(36,573)
Total	$	69,334	$	70,145

At August 31, 2021, capital in progress on the balance sheet included $30.3 million associated with capital costs related to proprietary machinery and equipment for the Company’s next generation of delivery systems for its WD-40 Smart Straw^® products. During the six months ended February 28, 2022, $13.5 million of this machinery and equipment was placed in service and thus the Company reclassified these amounts from capital in progress to machinery, equipment and vehicles.

As of February 28, 2022 and August 31, 2021, the Company’s balance sheet included $4.7 million and $2.6 million, respectively, of capitalized cloud-based implementation costs recorded as other assets within the Company’s condensed consolidated balance sheets. Accumulated amortization associated with these assets were not significant as of February 28, 2022 and August 31, 2021. Amortization expense associated with these assets were not significant for the three or six months ended February 28, 2022 or February 28, 2021.

XML

Goodwill And Other Intangible Assets

6 Months Ended

Feb. 28, 2022

Goodwill And Other Intangible Assets [Abstract]

Goodwill And Other Intangible Assets

Note 5. Goodwill and Other Intangible Assets

Goodwill

The following table summarizes the changes in the carrying amounts of goodwill by segment (in thousands):

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	85,476	$	9,184	$	1,209	$	95,869
Translation adjustments		(12)		(103)		-		(115)
Balance as of February 28, 2022	$	85,464	$	9,081	$	1,209	$	95,754

During the second quarter of fiscal year 2022, the Company performed its annual goodwill impairment test. The annual goodwill impairment test was performed at the reporting unit level as required by the authoritative guidance as of the Company’s most recent goodwill impairment testing date, December 1, 2021. During the fiscal year 2022 annual goodwill impairment test, the Company performed a qualitative assessment of each reporting unit to determine whether it was more likely than not that the fair value of a reporting unit was less than its carrying amount. In performing this qualitative assessment, the Company assessed relevant events and circumstances that may impact the fair value and the carrying amount of each of its reporting units. Factors that were considered included, but were not limited to, the following: (1) macroeconomic conditions, including the impacts of the COVID-19 pandemic; (2) industry and market conditions; (3) historical financial performance and expected financial performance; (4) other entity specific events, such as changes in management or key personnel; and (5) events affecting the Company’s reporting units, such as a change in the composition of net assets or any expected dispositions.

‎

Based on the results of this qualitative assessment, the Company determined that the estimated fair value of each of the Company’s reporting units exceeded their respective carrying values so significantly that an impairment charge to the Company’s goodwill balances is remote and, thus, a quantitative analysis was not required. As a result, the Company concluded that no impairment of its goodwill existed as of December 1, 2021. In addition, the Company concluded that there were no indicators of impairment identified as a result of the Company’s review of events and circumstances related to its goodwill subsequent to December 1, 2021 through February 28, 2022. To date, there have been no impairment losses identified and recorded related to the Company’s goodwill.

Definite-lived Intangible Assets

The Company’s definite-lived intangible assets, which include the Spot Shot, Carpet Fresh, 1001, EZ REACH and GT85 trade names, are included in other intangible assets, net in the Company’s condensed consolidated balance sheets. The following table summarizes the definite-lived intangible assets and the related accumulated amortization (in thousands):

	February 28,		August 31,
	2022		2021
Gross carrying amount	$	36,407	$	36,657
Accumulated amortization		(29,929)		(29,413)
Net carrying amount	$	6,478	$	7,244

There has been no impairment charge for the six months ended February 28, 2022 and there were no indicators of impairment identified as a result of the Company’s review of events and circumstances related to its existing definite-lived intangible assets. The Company’s review of events and circumstances included consideration of the ongoing COVID-19 pandemic.

Changes in the carrying amounts of definite-lived intangible assets by segment for the six months ended February 28, 2022 are summarized below (in thousands):

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	5,495	$	1,749	$	-	$	7,244
Amortization expense		(528)		(195)		-		(723)
Translation adjustments		-		(43)		-		(43)
Balance as of February 28, 2022	$	4,967	$	1,511	$	-	$	6,478

The estimated amortization expense for the Company’s definite-lived intangible assets is not significant in any future individual fiscal year.

‎

XML

Accrued And Other Liabilities

6 Months Ended

Feb. 28, 2022

Accrued And Other Liabilities [Abstract]

Accrued And Other Liabilities

Note 6. Accrued and Other Liabilities

Accrued liabilities consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Accrued advertising and sales promotion expenses	$	12,308	$	11,796
Accrued professional services fees		2,134		2,122
Accrued sales taxes and other taxes		3,462		1,708
Deferred revenue		3,976		3,696
Short-term operating lease liability		1,866		1,903
Other		4,384		4,433
Total	$	28,130	$	25,658

Accrued payroll and related expenses consisted of the following (in thousands): 

	February 28,		August 31,
	2022		2021
Accrued incentive compensation	$	4,800	$	14,068
Accrued payroll		4,728		4,746
Accrued profit sharing		1,068		3,273
Accrued payroll taxes		1,975		2,952
Other		562		623
Total	$	13,133	$	25,662

XML

Debt

6 Months Ended

Feb. 28, 2022

Debt [Abstract]

Debt

Note 7. Debt

As of February 28, 2022, the Company held borrowings under two separate agreements as detailed below.

Note Purchase and Private Shelf Agreement

The Company holds borrowings under its Note Purchase and Private Shelf Agreement (the “Note Agreement”) by and among the Company, PGIM, Inc. (“Prudential”), and certain affiliates and managed accounts of Prudential (the “Note Purchasers”). As of February 28, 2022, the Company had outstanding balances on its series A, B and C notes issued under this Note Agreement.

Credit Agreement

The Company’s Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America consists of a revolving commitment for borrowing by the Company up to $150.0 million with a sublimit of $100.0 million for WD-40 Company Limited, a wholly owned operating subsidiary of the Company for Europe, the Middle East, Africa and India. The Credit Agreement currently has a maturity date of September 30, 2025.

On November 29, 2021, the Company entered into its most recent amendment to the Credit Agreement (the “LIBOR Amendment”) with Bank of America. The LIBOR Amendment changed the Company’s index rates under the Credit Agreement for British Pound Sterling and U.S. Dollar borrowings from the London Interbank Offered Rate as administered by ICE Benchmark Administration to the Sterling Overnight Index Average Reference Rate and the Bloomberg Short-term Bank Yield Index rate, respectively, as well as certain definitions and clarifications within the Credit Agreement to accommodate the change in index rates. The impact of the LIBOR Amendment was insignificant to the Company’s consolidated financial statements.

Short-term and long-term borrowings under the Company’s Credit Agreement and Note Agreement consisted of the following (in thousands):

			February 28,		August 31,
	Issuance	Maturities	2022		2021
Credit Agreement - revolving credit facility (1)	Various	9/30/2025	$	46,047	$	46,540
Note Agreement
Series A Notes - 3.39% fixed rate(2)	11/15/2017	2021-2032		16,800		17,200
Series B Notes - 2.50% fixed rate(3)	9/30/2020	11/15/2027		26,000		26,000
Series C Notes - 2.69% fixed rate(3)	9/30/2020	11/15/2030		26,000		26,000
Total borrowings				114,847		115,740
Short-term portion of borrowings				(2,038)		(800)
Total long-term borrowings			$	112,809	$	114,940

(1)The Company has the ability to refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million on this facility is classified as long-term and is denominated in Euros and Pound Sterling, whereas $1.2 million is classified as short-term and is denominated in U.S. Dollar. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.

(2)Principal payments are required semi-annually in May and November of each year in equal installments of $0.4 million through May 15, 2032, resulting in $0.8 million classified as short-term. The remaining outstanding principal in the amount of $8.4 million will become due on November 15, 2032.

(3)Interest on notes is payable semi-annually in May and November of each year with no principal due until the maturity date.

Both the Note Agreement and the Credit Agreement contain representations, warranties, events of default and remedies, as well as affirmative, negative and other financial covenants customary for these types of agreements. These covenants include, among other things, certain limitations on the ability of the Company and its subsidiaries to incur indebtedness, create liens, dispose of assets, make investments, declare, make or incur obligations to make certain restricted payments, including the payment of dividends and payments for the repurchase of the Company’s capital stock and enter into certain merger or consolidation transactions. The Credit Agreement includes, among other limitations on indebtedness, a $125.0 million limit on other unsecured indebtedness.

Each agreement also includes a most favored lender provision which requires that any time any other lender has the benefit of one or more financial or operational covenants that is different than, or similar to, but more restrictive than those contained in its own agreement, those covenants shall be immediately and automatically incorporated by reference to the other lender’s agreement. Both the Note Agreement and the Credit Agreement require the Company to adhere to the same financial covenants. For the financial covenants, the definition of consolidated EBITDA includes the add back of non-cash stock-based compensation to consolidated net income when arriving at consolidated EBITDA. The terms of the financial covenants are as follows:

The consolidated leverage ratio cannot be greater than three and a half to one. The consolidated leverage ratio means, as of any date of determination, the ratio of (a) consolidated funded indebtedness as of such date to (b) consolidated EBITDA for the most recently completed four fiscal quarters.

The consolidated interest coverage ratio cannot be less than three to one. The consolidated interest coverage ratio means, as of any date of determination, the ratio of (a) consolidated EBITDA for the most recently completed four fiscal quarters to (b) consolidated interest charges for the most recently completed four fiscal quarters

As of February 28, 2022, the Company was in compliance with all debt covenants under both the Note Agreement and the Credit Agreement.

‎

XML

Share Repurchase Plan

6 Months Ended

Feb. 28, 2022

Share Repurchase Plan [Abstract]

Share Repurchase Plan

Note 8. Share Repurchase PlanOn October 12, 2021, the Company’s Board of Directors (“Board”) approved a new share repurchase plan. Under the plan, which became effective on November 1, 2021, the Company is authorized to acquire up to $75.0 million of its outstanding shares through August 31, 2023. The timing and amount of repurchases are based on terms and conditions as may be acceptable to the Company’s Chief Executive Officer and Chief Financial Officer, subject to present loan covenants and in compliance with all laws and regulations applicable thereto. During the period from November 1, 2021 through February 28, 2022, the Company repurchased 78,637 shares at an average price of $230.98 per share, for a total cost of $18.2 million under this $75.0 million plan.

XML

Earnings Per Common Share

6 Months Ended

Feb. 28, 2022

Earnings Per Common Share [Abstract]

Earnings Per Common Share

Note 9. Earnings per Common Share

The table below reconciles net income to net income available to common shareholders (in thousands):

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Net income	$	19,508	$	17,191	$	38,063	$	40,814
Less: Net income allocated to
participating securities		(73)		(64)		(137)		(174)
Net income available to common shareholders	$	19,435	$	17,127	$	37,926	$	40,640

The table below summarizes the weighted-average number of common shares outstanding included in the calculation of basic and diluted EPS (in thousands):

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Weighted-average common
shares outstanding, basic		13,679		13,700		13,773		13,687
Weighted-average dilutive securities		25		29		31		31
Weighted-average common
shares outstanding, diluted		13,704		13,729		13,804		13,718

For the three and six months ended February 28, 2022, weighted-average stock-based equity awards outstanding that are non-participating securities in the amount of 9,280 and 7,212, respectively, were excluded from the calculation of diluted EPS under the treasury stock method as they were anti-dilutive. For the three and six months ended February 28, 2021, there were no anti-dilutive stock-based equity awards outstanding.

‎

XML

Revenue Recognition

6 Months Ended

Feb. 28, 2022

Revenue Recognition [Abstract]

Revenue Recognition

Note 10. Revenue Recognition

Disaggregation of Revenue

The following table presents our revenues by segment and major source (in thousands):

:

	Three Months Ended February 28, 2022:								Six Months Ended February 28, 2022:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	50,409	$	52,093	$	19,399	$	121,901	$	102,393	$	107,536	$	38,002	$	247,931
HCCP (1)		4,088		1,970		2,027		8,085		8,392		4,082		4,327		16,801
Total net sales	$	54,497	$	54,063	$	21,426	$	129,986	$	110,785	$	111,618	$	42,329	$	264,732
	Three Months Ended February 28, 2021:								Six Months Ended February 28, 2021:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	41,310	$	47,736	$	13,682	$	102,728	$	89,812	$	100,114	$	27,146	$	217,072
HCCP (1)		4,847		2,077		2,253		9,177		10,532		4,449		4,411		19,392
Total net sales	$	46,157	$	49,813	$	15,935	$	111,905	$	100,344	$	104,563	$	31,557	$	236,464

(1)Homecare and cleaning products (“HCCP”)

Contract Balances

Contract liabilities consist of deferred revenue related to undelivered products. Deferred revenue is recorded when payments have been received from customers for undelivered products. Revenue is subsequently recognized when revenue recognition criteria are met, generally when control of the product transfers to the customer. The Company had contract liabilities of $4.0 million and $3.7 million as of February 28, 2022 and August 31, 2021, respectively. All of the $3.7 million that was included in contract liabilities as of August 31, 2021 was recognized to revenue during the six months ended February 28, 2022. These contract liabilities are recorded in accrued liabilities on the Company’s condensed consolidated balance sheets. The Company did not have any contract assets as of February 28, 2022 and August 31, 2021.

XML

Commitments And Contingencies

6 Months Ended

Feb. 28, 2022

Commitments And Contingencies [Abstract]

Commitments And Contingencies

Note 11. Commitments and Contingencies

Purchase Commitments

The Company has ongoing relationships with various suppliers (contract manufacturers) that manufacture the Company’s products and third-party distribution centers that warehouse and ship the Company’s products to customers. The contract manufacturers maintain title and control of certain raw materials and components, materials utilized in finished products, and of the finished products themselves until shipment to the Company’s customers or third-party distribution centers in accordance with agreed upon shipment terms. Although the Company has definitive minimum purchase obligations included in the contract terms with certain of its contract manufacturers, when such obligations have been included, they have either been immaterial or the minimum amounts have been such that they are well below the volume of goods that the Company has historically purchased. In the ordinary course of business, supply needs are communicated by the Company to its contract manufacturers based on orders and short-term projections, ranging from two months to six months. The Company is committed to purchase the products produced by the contract manufacturers based on the projections provided.

Upon the termination of contracts with contract manufacturers, the Company obtains certain inventory control rights and is obligated to work with the contract manufacturer to sell through all product held by or manufactured by the contract manufacturer on behalf of the Company during the termination notification period. If any inventory remains at the contract manufacturer at the termination date, the Company is obligated to purchase such inventory which may include raw materials, components and finished goods. The amounts for inventory purchased under termination commitments have been immaterial. 

In addition to the commitments to purchase products from contract manufacturers described above, the Company may also enter into commitments with other manufacturers to purchase finished goods and components to support innovation and renovation initiatives and/or supply chain initiatives. As of February 28, 2022, no such commitments were outstanding.

Litigation

From time to time, the Company is subject to various claims, lawsuits, investigations and proceedings arising in the ordinary course of business, including but not limited to, product liability litigation and other claims and proceedings with respect to intellectual property, breach of contract, labor and employment, tax and other matters. As of February 28, 2022, there were no unasserted claims or pending proceedings for claims against the Company that the Company believes will result in a probable loss. As to claims that the Company believes may result in a reasonably possible loss, the Company believes that no reasonably possible outcome of any such claim will have a materially adverse impact on the Company’s financial condition, results of operations or cash flows.

For further information on the risks the Company faces from existing and future claims, lawsuits, investigations and proceedings, see the Company’s risk factors disclosed in Part I―Item 1A, “Risk Factors,” in its Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

Indemnifications

As permitted under Delaware law, the Company has agreements whereby it indemnifies senior officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The maximum potential future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company maintains Director and Officer insurance coverage that mitigates the Company’s exposure with respect to such obligations. As a result of the Company’s insurance coverage, management believes that the estimated fair value of these indemnification agreements is minimal. Thus, no liabilities have been recorded for these agreements as of February 28, 2022.

From time to time, the Company enters into indemnification agreements with certain contractual parties in the ordinary course of business, including agreements with lenders, lessors, contract manufacturers, marketing distributors, customers and certain vendors. All such indemnification agreements are entered into in the context of the particular agreements and are provided in an attempt to properly allocate risk of loss in connection with the consummation of the underlying contractual arrangements. Although the maximum future payments that the Company could be required to make under these indemnification agreements is unlimited, management believes that the Company maintains adequate levels of insurance coverage to protect the Company with respect to most potential claims arising from such agreements and that such agreements do not otherwise have value separate and apart from the liabilities incurred in the ordinary course of the Company’s business. Thus, no liabilities have been recorded with respect to such indemnification agreements as of February 28, 2022.

XML

Income Taxes

6 Months Ended

Feb. 28, 2022

Income Taxes [Abstract]

Income Taxes

Note 12. Income Taxes

The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

The provision for income taxes was 20.1% and 15.0% of income before income taxes for the three months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to a non-recurring benefit received in the prior year from the settlement of stock-based equity awards.

The provision for income taxes was 19.9% and 15.4% of income before income taxes for the six months ended February 28, 2022 and 2021, respectively. The increase in the effective income tax rate from period to period was primarily due to non-recurring benefits received in the prior year from stock-based compensation, coupled with an increase in performance-based compensation that is not deductible for tax purposes in the current year.

The Company is subject to taxation in the U.S. and in various state and foreign jurisdictions. Due to expired statutes, the Company’s federal income tax returns for years prior to fiscal year 2018 are not subject to examination by the U.S. Internal Revenue Service. Generally, for the majority of state and foreign jurisdictions where the Company does business, periods prior to fiscal year 2018 are no longer subject to examination. The Company is currently under audit in various state jurisdictions for fiscal years 2018 through 2020. Estimated unrecognized tax benefits related to income tax positions affected

by the resolution of tax examinations or expiring statutes of limitation within the next twelve months were not significant. Audit outcomes and the timing of settlements are subject to significant uncertainty.

XML

Business Segments And Foreign Operations

6 Months Ended

Feb. 28, 2022

Business Segments And Foreign Operations [Abstract]

Business Segments And Foreign Operations

Note 13. Business Segments and Foreign Operations

The Company evaluates the performance of its segments and allocates resources to them based on sales and operating income. The Company is organized on the basis of geographical area into the following three segments: the Americas; EMEA; and Asia-Pacific. Segment data does not include inter-segment revenues. Unallocated corporate expenses are general corporate overhead expenses not directly attributable to the business segments and are reported separate from the Company’s identified segments. The corporate overhead costs include expenses for the Company’s accounting and finance, information technology, human resources, research and development, quality control and executive management functions, as well as all direct costs associated with public company compliance matters including legal, audit and other professional services costs.

Summary information about reportable segments is as follows (in thousands):

							Unallocated
For the Three Months Ended	Americas		EMEA		Asia-Pacific		Corporate (1)		Total
February 28, 2022:
Net sales	$	54,497	$	54,063	$	21,426	$	-	$	129,986
Income from operations	$	11,217	$	13,715	$	7,925	$	(8,114)	$	24,743
Depreciation and
amortization expense	$	1,169	$	813	$	70	$	43	$	2,095
Interest income	$	-	$	-	$	21	$	-	$	21
Interest expense	$	486	$	125	$	2	$	-	$	613
February 28, 2021:
Net sales	$	46,157	$	49,813	$	15,935	$	-	$	111,905
Income from operations	$	10,356	$	14,176	$	5,188	$	(9,065)	$	20,655
Depreciation and
amortization expense	$	795	$	807	$	75	$	80	$	1,757
Interest income	$	-	$	3	$	16	$	-	$	19
Interest expense	$	491	$	118	$	1	$	-	$	610
Six Months Ended:
February 28, 2022:
Net sales	$	110,785	$	111,618	$	42,329	$	-	$	264,732
Income from operations	$	23,234	$	27,928	$	15,227	$	(17,586)	$	48,803
Depreciation and
amortization expense	$	2,212	$	1,597	$	144	$	129	$	4,082
Interest income	$	-	$	-	$	46	$	-	$	46
Interest expense	$	984	$	246	$	3	$	-	$	1,233
February 28, 2021:
Net sales	$	100,344	$	104,563	$	31,557	$	-	$	236,464
Income from operations	$	24,982	$	31,919	$	10,247	$	(18,101)	$	49,047
Depreciation and
amortization expense	$	1,586	$	1,563	$	151	$	158	$	3,458
Interest income	$	1	$	5	$	32	$	-	$	38
Interest expense	$	946	$	232	$	2	$	-	$	1,180

(1)Unallocated corporate expenses are general corporate overhead expenses not directly attributable to any one of the business segments. These expenses are reported separate from the Company’s identified segments and are included in Selling, General and Administrative expenses on the Company’s condensed consolidated statements of operations.

The Company’s Chief Operating Decision Maker does not review assets by segment as part of the financial information provided, and therefore, no asset information is provided in the above table.

XML

Subsequent Events

6 Months Ended

Feb. 28, 2022

Subsequent Events [Abstract]

Subsequent Events

Note 14. Subsequent Events

Dividend Declaration

On March 15, 2022, the Company’s Board declared a cash dividend of $0.78 per share payable on April 29, 2022 to shareholders of record on April 15, 2022.

Changes to Executive Leadership and the Board

On March 15, 2022, the Board adopted a resolution to increase the size of the Board from ten to eleven, effective immediately.

On March 16, 2022, the Company announced the (i) retirement of Garry O. Ridge as CEO of the Company, effective August 31, 2022, (ii) the appointment of Steven A. Brass, currently the President and Chief Operating Officer (“COO”) of the Company, as CEO, effective September 1, 2022, and (iii) the appointment of Mr. Brass to the Board, effective March 15, 2022.

Mr. Ridge will remain as an employee of the Company until January 2, 2023, after which he will serve as a consultant to the Company until June 30, 2023, and will remain on the Board of the Company and serve as Chairman, until December 13, 2022.

In connection with Mr. Ridge’s retirement, the Company and Mr. Ridge entered into a Transition and Release Agreement on March 11, 2022 (the “Transition Agreement”) and signed the FY 2022 Restricted Stock Unit Award Agreement (“RSU Agreement”). Pursuant to the Transition Agreement, the Company granted him 5,347 restricted stock units (with a value of $1.0 million) with a grant date of March 17, 2022, which are scheduled to vest on June 30, 2023, subject to certain terms and conditions in the Transition Agreement and/or the RSU Agreement.

The foregoing description of the terms and conditions of the Transition Agreement and the RSU Agreement does not purport to be complete and is qualified in its entirety by reference to the Transition Agreement and the RSU Agreement, which are filed as Exhibit 10(c) and Exhibit 10(d), respectively, included in Part II-Item 6, “Exhibits” and incorporated by reference in this report.

XML

Basis Of Presentation And Summary Of Significant Accounting Policies (Policy)

6 Months Ended

Feb. 28, 2022

Basis Of Presentation And Summary Of Significant Accounting Policies [Abstract]

Basis Of Consolidation

Basis of Consolidation

The condensed consolidated financial statements included herein have been prepared by the Company, without audit, according to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The August 31, 2021 year-end condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP.

In the opinion of management, the unaudited financial information for the interim periods shown reflects all adjustments necessary for a fair statement thereof and such adjustments are of a normal recurring nature. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2021, which was filed with the SEC on October 22, 2021.

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use Of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.

COVID-19 Considerations

COVID-19 Considerations

The COVID-19 pandemic has adversely impacted global economic conditions and has contributed to significant volatility in financial markets beginning in early calendar year 2020, as described in the “Impact of COVID-19 on Our Business” portion of the section titled “Significant Developments” included in Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Although the Company’s estimates consider current conditions, the inputs into certain of the Company’s significant and critical accounting estimates include judgments and assumptions about the economic implications of the COVID-19 pandemic and how management expects them to change in the future, as appropriate.

It is reasonably possible that actual results experienced may differ materially from the Company’s estimates in future periods, which could materially affect our results of operations and financial condition.

Fair Value Of Financial Instruments

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures”, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial assets and liabilities measured at fair value into a hierarchy that categorizes fair value measurements into the following three levels based on the types of inputs used in measuring their fair value: 

Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities;

Level 2: Observable market-based inputs or observable inputs that are corroborated by market data; and

Level 3: Unobservable inputs reflecting the Company’s own assumptions.

Under fair value accounting, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. As of February 28, 2022, the Company had no assets or liabilities that are measured at fair value in the financial statements on a recurring basis, with the exception of the foreign currency forward contracts, which are classified as Level 2 within the fair value hierarchy. The carrying values of cash equivalents and short-term borrowings are recorded at cost, which approximates their fair values, primarily due to their short-term nature. In addition, the carrying value of borrowings held under the Company’s revolving credit facility approximates fair value, based on Level 2 inputs, due to the variable nature of underlying interest rates, which generally reflect market conditions. The Company’s fixed rate long-term borrowings consist of senior notes and are recorded at carrying value. The Company estimates that the fair value of its senior notes, based on Level 2 inputs, was approximately $64.8 million as of February 28, 2022, which was determined based on a discounted cash flow analysis using current market interest rates for instruments with similar terms, compared to their carrying value of $68.8 million. During the six months ended February 28, 2022, the Company did not record any significant nonrecurring fair value measurements for assets or liabilities in periods subsequent to their initial recognition.

Foreign Currency Forward Contracts

Foreign Currency Forward Contracts

In the normal course of business, the Company employs established policies and procedures to manage its exposure to fluctuations in foreign currency exchange rates. The Company utilizes foreign currency forward contracts to limit its exposure to net asset balances held in non-functional currencies, primarily at its U.K. subsidiary. The Company regularly monitors its foreign currency exchange rate exposures to ensure the overall effectiveness of its foreign currency hedge positions. While the Company engages in foreign currency hedging activity to reduce its risk, for accounting purposes, none of its foreign currency forward contracts are designated as hedges.

Foreign currency forward contracts are carried at fair value, with net realized and unrealized gains and losses recognized in other income (expense), net in the Company’s consolidated statements of operations. Cash flows from settlements of foreign currency forward contracts are included in operating activities in the consolidated statements of cash flows. Foreign currency forward contracts in an asset position at the end of the reporting period are included in other current assets, while foreign currency forward contracts in a liability position at the end of the reporting period are included in accrued liabilities in the Company’s consolidated balance sheets. At February 28, 2022, the Company had a notional amount of $4.5 million outstanding in foreign currency forward contracts, which matured on March 30, 2022. Unrealized net gains and losses related to foreign currency forward contracts were not significant at February 28, 2022 and August 31, 2021. Realized net gains and losses related to foreign currency forward contracts were not significant for both the three and six months ended February 28, 2022 and 2021. Both unrealized and realized net gains and losses are recorded in other income (expense), net on the Company’s condensed consolidated statements of operations.

Internal-Use Software and Cloud Computing Arrangements

Internal-Use Software and Cloud Computing Arrangements

The Company capitalizes costs related to computer software obtained or developed for internal use. Software obtained for internal use has generally been enterprise-level business and finance software that the Company customizes to meet its specific operational needs. Costs incurred in the application development phase are capitalized as property and equipment in the Company’s consolidated balance sheets and are depreciated using the straight-line method over their estimated useful lives.

The Company also enters into certain cloud-based software hosting arrangements. In evaluating whether cloud computing arrangements include an embedded internal-use software license, management considers whether the Company has the contractual right to take possession of the software during the hosting period without significant penalty and whether it is feasible to either i) run the software on the Company’s hardware, or ii) contract with another party unrelated to the vendor to host the software. If management determines a cloud computing arrangement includes an embedded software license, the Company accounts for the software license element of the arrangement consistent with the acquisition of other internal-use software licenses. If a cloud computing arrangement does not include a software license, the Company accounts for the arrangement as a service contract. For such cloud computing service contracts, the Company capitalizes certain implementation costs such as the configuration, coding and customization of the software. Capitalizable cloud computing arrangement costs are generally consistent with those incurred during the application development stage for internal-use software, however, these costs are capitalized as “other assets” in the Company’s consolidated balance sheets. The Company amortizes these capitalized cloud computing implementation costs into selling, general and administrative expenses using the straight-line method over the fixed, non-cancellable term of the associated hosting arrangement, plus any reasonably certain renewal periods.

The useful lives of the Company’s internal-use software and capitalized cloud computing implementation costs are generally three to five years. However, the useful lives of major information system installations such as implementations of enterprise resource planning (“ERP”) systems are determined on an individual basis and may exceed five years depending on the estimated period of use. The Company applies the same impairment model to both internal-use software and capitalized cloud computing implementation costs.

Recently Adopted Accounting Standards

Recently Adopted Accounting StandardsIn December 2019, the FASB issued ASU No. 2019-12, “Simplifying the Accounting for Income Taxes” under ASC 740, which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amended existing guidance to improve consistent application. This guidance is effective for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The Company adopted this new guidance on September 1, 2021, and the adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.

XML

Inventories (Tables)

6 Months Ended

Feb. 28, 2022

Inventories [Abstract]

Schedule Of Inventories

	February 28,		August 31,
	2022		2021
Product held at third-party contract manufacturers	$	7,218	$	9,036
Raw materials and components		12,526		8,981
Work-in-process		1,379		802
Finished goods		54,414		36,933
Total	$	75,537	$	55,752

XML

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs (Tables)

6 Months Ended

Feb. 28, 2022

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs [Abstract]

Schedule Of Property And Equipment, Net

	February 28,		August 31,
	2022		2021
Machinery, equipment and vehicles	$	36,004	$	22,504
Buildings and improvements		29,655		29,697
Computer and office equipment		6,094		5,742
Internal-use software		10,785		10,559
Furniture and fixtures		2,809		2,794
Capital in progress		18,236		31,016
Land		4,379		4,406
Subtotal		107,962		106,718
Less: accumulated depreciation and amortization		(38,628)		(36,573)
Total	$	69,334	$	70,145

XML

Goodwill And Other Intangible Assets (Tables)

6 Months Ended

Feb. 28, 2022

Goodwill And Other Intangible Assets [Abstract]

Summary Of Changes In Carrying Amounts Of Goodwill

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	85,476	$	9,184	$	1,209	$	95,869
Translation adjustments		(12)		(103)		-		(115)
Balance as of February 28, 2022	$	85,464	$	9,081	$	1,209	$	95,754

Summary Of Definite-Lived Intangible Assets

	February 28,		August 31,
	2022		2021
Gross carrying amount	$	36,407	$	36,657
Accumulated amortization		(29,929)		(29,413)
Net carrying amount	$	6,478	$	7,244

Summary Of Changes In Carrying Amounts Of Definite-Lived Intangible Assets By Segment

	Americas		EMEA		Asia-Pacific		Total
Balance as of August 31, 2021	$	5,495	$	1,749	$	-	$	7,244
Amortization expense		(528)		(195)		-		(723)
Translation adjustments		-		(43)		-		(43)
Balance as of February 28, 2022	$	4,967	$	1,511	$	-	$	6,478

XML

Accrued And Other Liabilities (Tables)

6 Months Ended

Feb. 28, 2022

Accrued And Other Liabilities [Abstract]

Schedule Of Accrued Liabilities

	February 28,		August 31,
	2022		2021
Accrued advertising and sales promotion expenses	$	12,308	$	11,796
Accrued professional services fees		2,134		2,122
Accrued sales taxes and other taxes		3,462		1,708
Deferred revenue		3,976		3,696
Short-term operating lease liability		1,866		1,903
Other		4,384		4,433
Total	$	28,130	$	25,658

Schedule Of Accrued Payroll And Related Expenses

	February 28,		August 31,
	2022		2021
Accrued incentive compensation	$	4,800	$	14,068
Accrued payroll		4,728		4,746
Accrued profit sharing		1,068		3,273
Accrued payroll taxes		1,975		2,952
Other		562		623
Total	$	13,133	$	25,662

XML

Debt (Tables)

6 Months Ended

Feb. 28, 2022

Debt [Abstract]

Schedule Of Short-term And Long-term Borrowings

			February 28,		August 31,
	Issuance	Maturities	2022		2021
Credit Agreement - revolving credit facility (1)	Various	9/30/2025	$	46,047	$	46,540
Note Agreement
Series A Notes - 3.39% fixed rate(2)	11/15/2017	2021-2032		16,800		17,200
Series B Notes - 2.50% fixed rate(3)	9/30/2020	11/15/2027		26,000		26,000
Series C Notes - 2.69% fixed rate(3)	9/30/2020	11/15/2030		26,000		26,000
Total borrowings				114,847		115,740
Short-term portion of borrowings				(2,038)		(800)
Total long-term borrowings			$	112,809	$	114,940

(1)The Company has the ability to refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million on this facility is classified as long-term and is denominated in Euros and Pound Sterling, whereas $1.2 million is classified as short-term and is denominated in U.S. Dollar. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.

(2)Principal payments are required semi-annually in May and November of each year in equal installments of $0.4 million through May 15, 2032, resulting in $0.8 million classified as short-term. The remaining outstanding principal in the amount of $8.4 million will become due on November 15, 2032.

(3)Interest on notes is payable semi-annually in May and November of each year with no principal due until the maturity date.

XML

Earnings Per Common Share (Tables)

6 Months Ended

Feb. 28, 2022

Earnings Per Common Share [Abstract]

Schedule Of Reconciliation Of Net Income To Net Income Available To Common Shareholders

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Net income	$	19,508	$	17,191	$	38,063	$	40,814
Less: Net income allocated to
participating securities		(73)		(64)		(137)		(174)
Net income available to common shareholders	$	19,435	$	17,127	$	37,926	$	40,640

Schedule Of Weighted Average Number Of Shares

	Three Months Ended February 28,				Six Months Ended February 28,
	2022		2021		2022		2021
Weighted-average common
shares outstanding, basic		13,679		13,700		13,773		13,687
Weighted-average dilutive securities		25		29		31		31
Weighted-average common
shares outstanding, diluted		13,704		13,729		13,804		13,718

XML

Revenue Recognition (Tables)

6 Months Ended

Feb. 28, 2022

Revenue Recognition [Abstract]

Schedule Of Revenues By Segment And Major Source

	Three Months Ended February 28, 2022:								Six Months Ended February 28, 2022:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	50,409	$	52,093	$	19,399	$	121,901	$	102,393	$	107,536	$	38,002	$	247,931
HCCP (1)		4,088		1,970		2,027		8,085		8,392		4,082		4,327		16,801
Total net sales	$	54,497	$	54,063	$	21,426	$	129,986	$	110,785	$	111,618	$	42,329	$	264,732
	Three Months Ended February 28, 2021:								Six Months Ended February 28, 2021:
	Americas		EMEA		Asia-Pacific		Total		Americas		EMEA		Asia-Pacific		Total
Maintenance products	$	41,310	$	47,736	$	13,682	$	102,728	$	89,812	$	100,114	$	27,146	$	217,072
HCCP (1)		4,847		2,077		2,253		9,177		10,532		4,449		4,411		19,392
Total net sales	$	46,157	$	49,813	$	15,935	$	111,905	$	100,344	$	104,563	$	31,557	$	236,464

(1)Homecare and cleaning products (“HCCP”)

XML

Business Segments And Foreign Operations (Tables)

6 Months Ended

Feb. 28, 2022

Business Segments And Foreign Operations [Abstract]

Summarized Information By Reportable Segments

							Unallocated
For the Three Months Ended	Americas		EMEA		Asia-Pacific		Corporate (1)		Total
February 28, 2022:
Net sales	$	54,497	$	54,063	$	21,426	$	-	$	129,986
Income from operations	$	11,217	$	13,715	$	7,925	$	(8,114)	$	24,743
Depreciation and
amortization expense	$	1,169	$	813	$	70	$	43	$	2,095
Interest income	$	-	$	-	$	21	$	-	$	21
Interest expense	$	486	$	125	$	2	$	-	$	613
February 28, 2021:
Net sales	$	46,157	$	49,813	$	15,935	$	-	$	111,905
Income from operations	$	10,356	$	14,176	$	5,188	$	(9,065)	$	20,655
Depreciation and
amortization expense	$	795	$	807	$	75	$	80	$	1,757
Interest income	$	-	$	3	$	16	$	-	$	19
Interest expense	$	491	$	118	$	1	$	-	$	610
Six Months Ended:
February 28, 2022:
Net sales	$	110,785	$	111,618	$	42,329	$	-	$	264,732
Income from operations	$	23,234	$	27,928	$	15,227	$	(17,586)	$	48,803
Depreciation and
amortization expense	$	2,212	$	1,597	$	144	$	129	$	4,082
Interest income	$	-	$	-	$	46	$	-	$	46
Interest expense	$	984	$	246	$	3	$	-	$	1,233
February 28, 2021:
Net sales	$	100,344	$	104,563	$	31,557	$	-	$	236,464
Income from operations	$	24,982	$	31,919	$	10,247	$	(18,101)	$	49,047
Depreciation and
amortization expense	$	1,586	$	1,563	$	151	$	158	$	3,458
Interest income	$	1	$	5	$	32	$	-	$	38
Interest expense	$	946	$	232	$	2	$	-	$	1,180

(1)Unallocated corporate expenses are general corporate overhead expenses not directly attributable to any one of the business segments. These expenses are reported separate from the Company’s identified segments and are included in Selling, General and Administrative expenses on the Company’s condensed consolidated statements of operations.

XML

Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Realized foreign currency transactions	$ 0	$ 0	$ 0	$ 0
Unrealized foreign currency transactions			110,000	$ (139,000)
Carrying value of senior notes	112,809,000		112,809,000		$ 114,940,000
Assets	423,146,000		423,146,000		430,203,000
Liabilities	224,296,000		$ 224,296,000		229,821,000
Minimum [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Useful lives of internal use software and capitalized cloud computing implementation costs			3 years
Useful lives of major information systems installations estimated period of use			5 years
Maximum [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Useful lives of internal use software and capitalized cloud computing implementation costs			5 years
Foreign Currency Forward Contracts [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Foreign currency forward contracts outstanding	4,500,000		$ 4,500,000
Foreign currency forward contracts, Maturity date			Mar. 30, 2022
Unrealized foreign currency transactions			$ 0		$ 0
Level 2 [Member] | Recurring [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Assets	0		0
Liabilities	0		0
Level 2 [Member] | Nonrecurring [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Assets	0		0
Liabilities	0		0
Senior Notes [Member] | Level 2 [Member]
Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Fair value of senior notes	64,800,000		64,800,000
Carrying value of senior notes	$ 68,800,000		$ 68,800,000

XML

Inventories (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Inventories [Abstract]
Product held at third-party contract manufacturers	$ 7,218	$ 9,036
Raw materials and components	12,526	8,981
Work-in-process	1,379	802
Finished goods	54,414	36,933
Total	$ 75,537	$ 55,752

XML

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs (Narrative) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021	Aug. 31, 2021
Machinery, Equipment And Vehicles [Member]
Business Acquisition [Line Items]
Capital costs	$ 13,500,000		$ 13,500,000		$ 30,300,000
Capitalized Cloud-Based Asset [Member]
Business Acquisition [Line Items]
Capitalized implementation costs	4,700,000		4,700,000		2,600,000
Accumulated amortization	0		0		$ 0
Amortization expense	$ 0	$ 0	$ 0	$ 0

XML

Property and Equipment and Capitalized Cloud-Based Software Implementation Costs (Schedule Of Property And Equipment, Net) (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Property Plant And Equipment [Line Items]
Subtotal	$ 107,962	$ 106,718
Less: accumulated depreciation and amortization	(38,628)	(36,573)
Total	69,334	70,145
Machinery, Equipment And Vehicles [Member]
Property Plant And Equipment [Line Items]
Subtotal	36,004	22,504
Buildings And Improvements [Member]
Property Plant And Equipment [Line Items]
Subtotal	29,655	29,697
Computer And Office Equipment [Member]
Property Plant And Equipment [Line Items]
Subtotal	6,094	5,742
Internal-Use Software [Member]
Property Plant And Equipment [Line Items]
Subtotal	10,785	10,559
Furniture And Fixtures [Member]
Property Plant And Equipment [Line Items]
Subtotal	2,809	2,794
Capital In Progress [Member]
Property Plant And Equipment [Line Items]
Subtotal	18,236	31,016
Land [Member]
Property Plant And Equipment [Line Items]
Subtotal	$ 4,379	$ 4,406

XML

Goodwill And Other Intangible Assets (Narrative) (Details) - USD ($)	3 Months Ended	6 Months Ended
	Nov. 30, 2021	Feb. 28, 2022
Goodwill And Other Intangible Assets [Abstract]
Impairment of goodwill	$ 0	$ 0
Impairment charges		$ 0

XML

Goodwill And Other Intangible Assets (Summary Of Changes In Carrying Amounts Of Goodwill) (Details) $ in Thousands	6 Months Ended
	Feb. 28, 2022 USD ($)
Goodwill [Line Items]
Balance, beginning	$ 95,869
Translation adjustments	(115)
Balance, ending	95,754
Americas [Member]
Goodwill [Line Items]
Balance, beginning	85,476
Translation adjustments	(12)
Balance, ending	85,464
EMEA [Member]
Goodwill [Line Items]
Balance, beginning	9,184
Translation adjustments	(103)
Balance, ending	9,081
Asia-Pacific [Member]
Goodwill [Line Items]
Balance, beginning	1,209
Translation adjustments
Balance, ending	$ 1,209

XML

Goodwill And Other Intangible Assets (Summary Of Definite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Goodwill And Other Intangible Assets [Abstract]
Gross carrying amount	$ 36,407	$ 36,657
Accumulated amortization	(29,929)	(29,413)
Net carrying amount	$ 6,478	$ 7,244

XML

Goodwill And Other Intangible Assets (Summary Of Changes In Carrying Amounts Of Definite-Lived Intangible Assets By Segment) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Finite-Lived Intangible Assets [Line Items]
Beginning balance			$ 7,244
Amortization expense	$ (360)	$ (362)	(723)	$ (720)
Translation adjustments			(43)
Ending balance	6,478		6,478
Americas [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			5,495
Amortization expense			(528)
Translation adjustments
Ending balance	4,967		4,967
EMEA [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			1,749
Amortization expense			(195)
Translation adjustments			(43)
Ending balance	1,511		1,511
Asia-Pacific [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance
Amortization expense
Translation adjustments
Ending balance

XML

Accrued And Other Liabilities (Schedule Of Accrued Liabilities) (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Accrued And Other Liabilities [Abstract]
Accrued advertising and sales promotion expenses	$ 12,308	$ 11,796
Accrued professional services fees	2,134	2,122
Accrued sales taxes and other taxes	3,462	1,708
Deferred revenue	3,976	3,696
Short-term operating lease liability	1,866	1,903
Other	4,384	4,433
Total	$ 28,130	$ 25,658

XML

Accrued And Other Liabilities (Schedule Of Accrued Payroll And Related Expenses) (Details) - USD ($) $ in Thousands	Feb. 28, 2022	Aug. 31, 2021
Accrued And Other Liabilities [Abstract]
Accrued incentive compensation	$ 4,800	$ 14,068
Accrued payroll	4,728	4,746
Accrued profit sharing	1,068	3,273
Accrued payroll taxes	1,975	2,952
Other	562	623
Total	$ 13,133	$ 25,662

XML

Debt (Narrative) (Details)	6 Months Ended
	Feb. 28, 2022 USD ($) agreement
Debt Instrument [Line Items]
Number of agreements | agreement	2
Other Unsecured Debt [Member]
Debt Instrument [Line Items]
Revolving credit facility, amount	$ 125,000,000.0
Note Agreement and the Credit Agreement [Member]
Debt Instrument [Line Items]
Consolidated leverage ratio	3.5
Consolidated interest coverage ratio	3
Credit Agreement - Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving credit facility, amount	$ 150,000,000.0
Maturity date	Sep. 30, 2025	[1]
Europe, The Middle East, Africa And India Subsidiary [Member] | Credit Agreement - Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving credit facility, amount	$ 100,000,000.0

[1] The Company has the ability to refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million on this facility is classified as long-term and is denominated in Euros and Pound Sterling, whereas $1.2 million is classified as short-term and is denominated in U.S. Dollar. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.

XML

Debt (Schedule Of Short-term And Long-term Borrowings) (Details) - USD ($) $ in Thousands		6 Months Ended
		Feb. 28, 2022	Aug. 31, 2021
Debt Instrument [Line Items]
Total Borrowings		$ 114,847	$ 115,740
Short-term portion of borrowings		(2,038)	(800)
Long-term borrowings		$ 112,809	114,940
Series A Notes [Member]
Debt Instrument [Line Items]
Issuance	[1]	Nov. 15, 2017
Maturity date		Nov. 15, 2032
Interest rate		3.39%
Total Borrowings	[1]	$ 16,800	17,200
Short term portion of long-term debt		$ 800
Principal payment frequency of periodic payment		semi-annually
Periodic payment amount		$ 400
Periodic principal maturity		May 15, 2032
Remaining principal payment		$ 8,400
Series B Notes [Member]
Debt Instrument [Line Items]
Issuance	[2]	Sep. 30, 2020
Maturity date	[2]	Nov. 15, 2027
Interest rate		2.50%
Total Borrowings	[2]	$ 26,000	26,000
Series C Notes [Member]
Debt Instrument [Line Items]
Issuance	[2]	Sep. 30, 2020
Maturity date	[2]	Nov. 15, 2030
Interest rate		2.69%
Total Borrowings	[2]	$ 26,000	26,000
Series B and Series C Notes [Member]
Debt Instrument [Line Items]
Principal payment frequency of periodic payment		semi-annually
Credit Agreement - Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Maturity date	[3]	Sep. 30, 2025
Total Borrowings	[3]	$ 46,047	$ 46,540
Long-term borrowings		44,800
Short term portion of long-term debt		$ 1,200
Minimum [Member] | Series A Notes [Member]
Debt Instrument [Line Items]
Maturity year	[1]	2021
Maximum [Member] | Series A Notes [Member]
Debt Instrument [Line Items]
Maturity year	[1]	2032

[1] Principal payments are required semi-annually in May and November of each year in equal installments of $0.4 million through May 15, 2032, resulting in $0.8 million classified as short-term. The remaining outstanding principal in the amount of $8.4 million will become due on November 15, 2032.

[2] Interest on notes is payable semi-annually in May and November of each year with no principal due until the maturity date.

[3] The Company has the ability to refinance any draw under the line of credit with successive short-term borrowings through the maturity date. Outstanding draws for which management has the ability and intent to refinance with successive short-term borrowings for a period of at least twelve months are classified as long-term. As of February 28, 2022, $44.8 million on this facility is classified as long-term and is denominated in Euros and Pound Sterling, whereas $1.2 million is classified as short-term and is denominated in U.S. Dollar. Euro and Pound Sterling denominated draws will fluctuate in U.S. Dollars from period to period due to changes in foreign currency exchange rates.

XML

Share Repurchase Plan (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	4 Months Ended	6 Months Ended
	Feb. 28, 2022	Feb. 28, 2022	Oct. 12, 2021
Share Repurchase Plan [Abstract]
Share buy-back plan, amount authorized			$ 75,000
Share buy-back plan, number of shares repurchased	78,637
Average price of shares repurchased	$ 230.98
Total cost of repurchased shares	$ 18,200	$ 18,165

XML

Earnings Per Common Share (Narrative) (Details) - shares	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Earnings Per Common Share [Abstract]
Anti-dilutive stock options outstanding	9,280	0	7,212	0

XML

Earnings Per Common Share (Schedule Of Reconciliation Of Net Income To Net Income Available To Common Shareholders) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Feb. 28, 2022	Nov. 30, 2021	Feb. 28, 2021	Nov. 30, 2020	Feb. 28, 2022	Feb. 28, 2021
Earnings Per Common Share [Abstract]
Net income	$ 19,508	$ 18,555	$ 17,191	$ 23,623	$ 38,063	$ 40,814
Less: Net income allocated to participating securities	(73)		(64)		(137)	(174)
Net income available to common shareholders	$ 19,435		$ 17,127		$ 37,926	$ 40,640

XML

Earnings Per Common Share (Schedule Of Weighted Average Number Of Shares) (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Earnings Per Common Share [Abstract]
Weighted-average common shares outstanding, basic	13,679	13,700	13,773	13,687
Weighted-average dilutive securities	25	29	31	31
Weighted-average common shares outstanding, diluted	13,704	13,729	13,804	13,718

XML

Revenue Recognition (Narrative) (Details) - USD ($)	Feb. 28, 2022	Aug. 31, 2021
Revenue Recognition [Abstract]
Contract liabilities	$ 4,000,000.0	$ 3,700,000
Contract assets	$ 0	$ 0

XML

Revenue Recognition (Schedule Of Revenues By Segment And Major Source) (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Revenue from External Customer [Line Items]
Total net sales		$ 129,986	$ 111,905	$ 264,732	$ 236,464
Maintenance Products [Member]
Revenue from External Customer [Line Items]
Total net sales		121,901	102,728	247,931	217,072
Homecare And Cleaning Products [Member]
Revenue from External Customer [Line Items]
Total net sales	[1]	8,085	9,177	16,801	19,392
Americas [Member]
Revenue from External Customer [Line Items]
Total net sales		54,497	46,157	110,785	100,344
Americas [Member] | Maintenance Products [Member]
Revenue from External Customer [Line Items]
Total net sales		50,409	41,310	102,393	89,812
Americas [Member] | Homecare And Cleaning Products [Member]
Revenue from External Customer [Line Items]
Total net sales	[1]	4,088	4,847	8,392	10,532
EMEA [Member]
Revenue from External Customer [Line Items]
Total net sales		54,063	49,813	111,618	104,563
EMEA [Member] | Maintenance Products [Member]
Revenue from External Customer [Line Items]
Total net sales		52,093	47,736	107,536	100,114
EMEA [Member] | Homecare And Cleaning Products [Member]
Revenue from External Customer [Line Items]
Total net sales	[1]	1,970	2,077	4,082	4,449
Asia-Pacific [Member]
Revenue from External Customer [Line Items]
Total net sales		21,426	15,935	42,329	31,557
Asia-Pacific [Member] | Maintenance Products [Member]
Revenue from External Customer [Line Items]
Total net sales		19,399	13,682	38,002	27,146
Asia-Pacific [Member] | Homecare And Cleaning Products [Member]
Revenue from External Customer [Line Items]
Total net sales	[1]	$ 2,027	$ 2,253	$ 4,327	$ 4,411

[1] Homecare and cleaning products (“HCCP”)

XML

Commitments And Contingencies (Narrative) (Details)	6 Months Ended
	Feb. 28, 2022 USD ($)
Purchase Commitment [Member]
Loss Contingencies [Line Items]
Commitment outstanding	$ 0
Indemnification Agreement 2 [Member]
Loss Contingencies [Line Items]
Liabilities related to indemnification agreement	0
Senior Officers And Directors [Member] | Indemnification Agreement 1 [Member]
Loss Contingencies [Line Items]
Liabilities related to indemnification agreement	$ 0
Minimum [Member] | Purchase Commitment [Member]
Loss Contingencies [Line Items]
Purchase commitment period	2 months
Maximum [Member] | Purchase Commitment [Member]
Loss Contingencies [Line Items]
Purchase commitment period	6 months

XML

Income Taxes (Narrative) (Details)	3 Months Ended		6 Months Ended
	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2022	Feb. 28, 2021
Income Taxes [Abstract]
Provision for income taxes	20.10%	15.00%	19.90%	15.40%

XML

Business Segments and Foreign Operations (Summarized Information By Reportable Segments) (Details) $ in Thousands		3 Months Ended		6 Months Ended
		Feb. 28, 2022 USD ($)	Feb. 28, 2021 USD ($)	Feb. 28, 2022 USD ($) item	Feb. 28, 2021 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | item				3
Net sales		$ 129,986	$ 111,905	$ 264,732	$ 236,464
Income from operations		24,743	20,655	48,803	49,047
Depreciation and amortization expense		2,095	1,757	4,082	3,458
Interest income		21	19	46	38
Interest expense		613	610	1,233	1,180
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Income from operations	[1]	(8,114)	(9,065)	(17,586)	(18,101)
Depreciation and amortization expense	[1]	43	80	129	158
Americas Segment [Member]
Segment Reporting Information [Line Items]
Net sales		54,497	46,157	110,785	100,344
Income from operations		11,217	10,356	23,234	24,982
Depreciation and amortization expense		1,169	795	2,212	1,586
Interest income					1
Interest expense		486	491	984	946
EMEA Segments [Member]
Segment Reporting Information [Line Items]
Net sales		54,063	49,813	111,618	104,563
Income from operations		13,715	14,176	27,928	31,919
Depreciation and amortization expense		813	807	1,597	1,563
Interest income			3		5
Interest expense		125	118	246	232
Asia-Pacific Segment [Member]
Segment Reporting Information [Line Items]
Net sales		21,426	15,935	42,329	31,557
Income from operations		7,925	5,188	15,227	10,247
Depreciation and amortization expense		70	75	144	151
Interest income		21	16	46	32
Interest expense		$ 2	$ 1	$ 3	$ 2

[1] Unallocated For the Three Months Ended Americas EMEA Asia-Pacific Corporate ⁽¹⁾ Total February 28, 2022: Net sales $ 54,497 $ 54,063 $ 21,426 $ - $ 129,986 Income from operations $ 11,217 $ 13,715 $ 7,925 $ (8,114) $ 24,743 Depreciation and amortization expense $ 1,169 $ 813 $ 70 $ 43 $ 2,095 Interest income $ - $ - $ 21 $ - $ 21 Interest expense $ 486 $ 125 $ 2 $ - $ 613 February 28, 2021: Net sales $ 46,157 $ 49,813 $ 15,935 $ - $ 111,905 Income from operations $ 10,356 $ 14,176 $ 5,188 $ (9,065) $ 20,655 Depreciation and amortization expense $ 795 $ 807 $ 75 $ 80 $ 1,757 Interest income $ - $ 3 $ 16 $ - $ 19 Interest expense $ 491 $ 118 $ 1 $ - $ 610 Six Months Ended: February 28, 2022: Net sales $ 110,785 $ 111,618 $ 42,329 $ - $ 264,732 Income from operations $ 23,234 $ 27,928 $ 15,227 $ (17,586) $ 48,803 Depreciation and amortization expense $ 2,212 $ 1,597 $ 144 $ 129 $ 4,082 Interest income $ - $ - $ 46 $ - $ 46 Interest expense $ 984 $ 246 $ 3 $ - $ 1,233 February 28, 2021: Net sales $ 100,344 $ 104,563 $ 31,557 $ - $ 236,464 Income from operations $ 24,982 $ 31,919 $ 10,247 $ (18,101) $ 49,047 Depreciation and amortization expense $ 1,586 $ 1,563 $ 151 $ 158 $ 3,458 Interest income $ 1 $ 5 $ 32 $ - $ 38 Interest expense $ 946 $ 232 $ 2 $ - $ 1,180 (1)Unallocated corporate expenses are general corporate overhead expenses not directly attributable to any one of the business segments. These expenses are reported separate from the Company’s identified segments and are included in Selling, General and Administrative expenses on the Company’s condensed consolidated statements of operations.

XML

Subsequent Events (Narrative) (Details) - Subsequent Events [Member] $ / shares in Units, $ in Millions	Mar. 15, 2022 employee $ / shares	Mar. 11, 2022 USD ($) shares
Subsequent Events [Line Items]
Cash dividend declared | $ / shares	$ 0.78
Dividends payable, date to be paid	Apr. 29, 2022
Dividend payable, record date	Apr. 15, 2022
Number of board members before increase	10
Number of board members after increase	11
Transition Agreement [Member] | Mr. Ridge [Member]
Subsequent Events [Line Items]
Shares granted | shares		5,347
Shares granted value | $		$ 1.0
Award vesting date		Jun. 30, 2023